Hill-Rom (HRC) 10-K 20 Nov 13 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Billions, except Share data, unless otherwise specified	Sep. 30, 2013	Nov. 13, 2013	Mar. 31, 2013
Document And Entity Information Abstract	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	30-Sep-13	'	'
Entity Registrant Name	'Hill-Rom Holdings, Inc.	'	'
Entity Central Index Key	'0000047518	'	'
Current Fiscal Year End Date	'--09-30	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	58,367,400	'
Entity Current Reporting Status	'Yes	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Public Float	'	'	$2.10

STATEMENTS_OF_CONSOLIDATED_INC

STATEMENTS OF CONSOLIDATED INCOME (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Net Revenue	'	'	'
Capital sales	$1,308.30	$1,198.20	$1,119
Rental revenue	407.9	436.1	472.7
Total revenue	1,716.20	1,634.30	1,591.70
Cost of Revenue	'	'	'
Cost of goods sold	747.8	690.4	606.8
Rental expenses	188.1	189.2	203.6
Total cost of revenue	935.9	879.6	810.4
Gross Profit	780.3	754.7	781.3
Research and development expenses	70.2	66.9	63.8
Selling and administrative expenses	549.5	496.4	502
Litigation (credit) charge (Note 13)	'	-3.6	47.3
Impairment of goodwill and other intangibles (Note 3)	'	8	'
Special charges (Note 8)	5.7	18.2	1.4
Operating Profit	154.9	168.8	166.8
Interest expense	-9.5	-6.5	-8.5
Investment income and other, net	-1.4	1.2	1.4
Income Before Income Taxes	144	163.5	159.7
Income tax expense (Note 9)	39	42.7	26.2
Net Income	105	120.8	133.5
Less: Net income attributable to noncontrolling interest	'	'	0.2
Net Income Attributable to Common Shareholders	$105	$120.80	$133.30
Net Income Attributable to Common Shareholders per Common Share - Basic	$1.75	$1.94	$2.11
Net Income Attributable to Common Shareholders per Common Share - Diluted	$1.74	$1.94	$2.09
Dividends per Common Share	$0.53	$0.49	$0.43
Average Common Shares Outstanding - Basic (thousands) (Note 10)	59,910	62,120	63,164
Average Common Shares Outstanding - Diluted (thousands) (Note 10)	60,250	62,361	63,899

STATEMENTS_OF_CONSOLIDATED_COM

STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME [Abstract]	'	'	'
Net Income Attributable to Common Shareholders	$105	$120.80	$133.30
Other Comprehensive Income (Loss):	'	'	'
Available-for-sale securities and currency hedges, net of tax of $0.0, ($0.2) and $0.0, respectively	0.1	0.5	-0.2
Foreign currency translation adjustment, net of tax of $0.0, $1.8 and $0.5, respectively	12.6	-1.5	-3.8
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, net of tax of ($18.1), ($1.6) and $8.9, respectively	29.6	2	-13.2
Total Other Comprehensive Income (Loss)	42.3	1	-17.2
Total Comprehensive Income	$147.30	$121.80	$116.10

STATEMENTS_OF_CONSOLIDATED_COM1

STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
STATEMENTS OF CONSOLIDATED COMPREHENSIVE INCOME [Abstract]	'	'	'
Available-for-sale securities and currency hedges, tax effect	$0	($0.20)	$0
Foreign currency translation adjustment, tax effect	0	1.8	0.5
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, tax effect	($18.10)	($1.60)	$8.90

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Sep. 30, 2012
In Millions, unless otherwise specified
Current Assets	'	'
Cash and cash equivalents	$127.40	$84.30
Trade accounts receivable, less allowances of $30.1 in 2013 and $38.5 in 2012 (Note 1)	361.8	392.6
Inventories (Note 1)	118.3	126.9
Deferred income taxes (Notes 1 and 9)	48.2	48.6
Other current assets	32.3	29.4
Total current assets	688	681.8
Property, plant and equipment (Note 1)	821.7	834.9
Less accumulated depreciation	-587.4	-584.8
Property, plant and equipment, net	234.3	250.1
Investments and investment securities (Notes 1 and 5)	7.3	7.3
Intangible assets:	'	'
Goodwill (Notes 1, 2 and 3)	342.8	335.2
Software and other, net (Notes 1 and 2)	252.7	290.8
Deferred income taxes (Notes 1 and 9)	37.5	38.9
Other assets	24.2	23.5
Total Assets	1,586.80	1,627.60
Current Liabilities	'	'
Trade accounts payable	80.8	80.7
Short-term borrowings (Note 4)	81.2	115.2
Accrued compensation	92.4	73.4
Accrued product warranties (Note 1)	38.1	42.2
Other current liabilities	52.9	66.6
Total current liabilities	345.4	378.1
Long-term debt (Note 4)	225.8	237.5
Accrued pension and postretirement benefits (Note 6)	52.6	89.6
Deferred income taxes (Notes 1 and 9)	67	68.1
Other long-term liabilities	37.3	41.7
Total Liabilities	728.1	815
Commitments and Contingencies (Note 13)	'	'
SHAREHOLDERS' EQUITY (Note 7)	'	'
Preferred stock - without par value: Authorized - 1,000,000 shares; none issued or outstanding	'	'
Common stock - without par value: Authorized - 199,000,000 Issued - 80,323,912 shares in 2013 and 2012	4.4	4.4
Additional paid-in-capital	122.7	116.8
Retained earnings	1,473.80	1,400.30
Accumulated other comprehensive loss (Note 1)	-35.7	-78
Treasury stock, common shares at cost: 2013 - 21,800,520 and 2012 - 19,526,989	-706.5	-630.9
Total Shareholders' Equity	858.7	812.6
Total Liabilities and Shareholders' Equity	$1,586.80	$1,627.60

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Sep. 30, 2012
In Millions, except Share data, unless otherwise specified
CONSOLIDATED BALANCE SHEETS [Abstract]	'	'
Trade accounts receivable, allowances	$30.10	$38.50
Preferred stock, no par value	'	'
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, no par value	'	'
Common stock, shares authorized	199,000,000	199,000,000
Common stock, shares issued	80,323,912	80,323,912
Treasury stock, shares	21,800,520	19,526,989

STATEMENTS_OF_CONSOLIDATED_CAS

STATEMENTS OF CONSOLIDATED CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Operating Activities	'	'	'
Net income	$105	$120.80	$133.50
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation	71.2	73.9	74.3
Amortization	45.6	37.8	29.6
Provision for deferred income taxes	-14.8	-32.3	-21.5
Loss on disposal of property, equipment leased to others, intangible assets and impairments	1.5	8.1	1.3
Stock compensation	13.5	11.6	12.2
Tax settlement	'	'	-4.9
Excess tax benefits from employee stock plans	-0.3	-1.3	-6.8
Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions:	'	'	'
Trade accounts receivable	30.8	20.1	-24.7
Inventories	8.4	4.4	14.7
Other current assets	-6.5	20.9	14.4
Trade accounts payable	0.1	0.3	-18
Accrued expenses and other liabilities	-0.2	-6.1	10
Other, net	8.9	3.5	8.4
Net cash provided by operating activities	263.2	261.7	222.5
Investing Activities	'	'	'
Capital expenditures and purchase of intangibles	-65.3	-77.8	-68.9
Proceeds on sales of property and equipment leased to others	5.9	10.6	5.9
Payment for acquisition of businesses, net of cash acquired	0.8	-476.8	-15.5
Proceeds on investment sales and maturities	'	4.5	0.5
Net cash used in investing activities	-58.6	-539.5	-78
Financing Activities	'	'	'
Net change in short-term debt	'	-7.8	-0.4
Borrowings on revolving credit facility	'	305	'
Payments on revolving credit facility	-35	-245	-0.2
Proceeds from long-term debt	'	200	'
Payment of long-term debt	-10.1	-50	'
Debt issuance costs	'	-2.6	'
Purchase of noncontrolling interest	-1.6	-1.6	-11.8
Payment of cash dividends	-31.2	-30.1	-27
Proceeds from exercise of stock options	7.6	7.7	43.1
Proceeds from stock issuance	2.5	2.9	2.9
Excess tax benefits from employee stock plans	0.3	1.3	6.8
Treasury stock acquired	-94	-44.2	-115.3
Net cash (used in) provided by financing activities	-161.5	135.6	-101.9
Effect of exchange rate changes on cash	'	1.9	-2.5
Net Cash Flows	43.1	-140.3	40.1
Cash and Cash Equivalents	'	'	'
At beginning of period	84.3	224.6	184.5
At end of period	127.4	84.3	224.6
Supplemental cash flow information:	'	'	'
Cash paid for income taxes	68.1	52.1	30.3
Cash paid for interest	7.5	6.6	7.7
Non-cash financing activities:	'	'	'
Treasury stock issued under stock compensation plans	$18.40	$21	$65.70

STATEMENTS_OF_CONSOLIDATED_SHA

STATEMENTS OF CONSOLIDATED SHAREHOLDERS' EQUITY (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Common Stock in Treasury [Member]
In Millions, except Share data
Balance at Sep. 30, 2010	$707.50	$4.40	$119.30	$1,203.60	($61.80)	($558)
Balance, shares at Sep. 30, 2010	'	62,786,883	'	'	'	-17,537,029
Net income	133.5	'	'	133.5	'	'
Other comprehensive income net of tax of ($18.1), $0.0, and $9.4 in 2013, 2012, and 2011	-17.2	'	'	'	-17.2	'
Dividends	-27	'	0.1	-27.1	'	'
Treasury shares acquired	-115.3	'	'	'	'	-115.3
Treasury shares acquired, shares	'	-3,145,899	'	'	'	3,145,899
Stock awards and option exercises	65.3	'	-0.4	'	'	65.7
Stock awards and option exercises, shares	'	2,045,388	'	'	'	-2,045,388
Impact of Joint Venture	-5.1	'	-4.9	-0.2	'	'
Balance at Sep. 30, 2011	741.7	4.4	114.1	1,309.80	-79	-607.6
Balance, shares at Sep. 30, 2011	'	61,686,372	'	'	'	-18,637,540
Net income	120.8	'	'	120.8	'	'
Other comprehensive income net of tax of ($18.1), $0.0, and $9.4 in 2013, 2012, and 2011	1	'	'	'	1	'
Dividends	-30.1	'	0.2	-30.3	'	'
Treasury shares acquired	-44.2	'	'	'	'	-44.2
Treasury shares acquired, shares	'	-1,532,232	'	'	'	1,532,232
Stock awards and option exercises	23.4	'	2.5	'	'	20.9
Stock awards and option exercises, shares	'	642,783	'	'	'	-642,783
Balance at Sep. 30, 2012	812.6	4.4	116.8	1,400.30	-78	-630.9
Balance, shares at Sep. 30, 2012	80,323,912	60,796,923	'	'	'	-19,526,989
Net income	105	'	'	105	'	'
Other comprehensive income net of tax of ($18.1), $0.0, and $9.4 in 2013, 2012, and 2011	42.3	'	'	'	42.3	'
Dividends	-31.2	'	0.3	-31.5	'	'
Treasury shares acquired	-94	'	'	'	'	-94
Treasury shares acquired, shares	'	-2,844,765	'	'	'	2,844,765
Stock awards and option exercises	24	'	5.6	'	'	18.4
Stock awards and option exercises, shares	'	571,234	'	'	'	-571,234
Balance at Sep. 30, 2013	$858.70	$4.40	$122.70	$1,473.80	($35.70)	($706.50)
Balance, shares at Sep. 30, 2013	80,323,912	58,523,392	'	'	'	-21,800,520

STATEMENTS_OF_CONSOLIDATED_SHA1

STATEMENTS OF CONSOLIDATED SHAREHOLDERS' EQUITY (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
STATEMENTS OF CONSOLIDATED SHAREHOLDERS' EQUITY [Abstract]	'	'	'
Comprehensive income, tax effect	($18.10)	$0	$9.40

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Nature of Operations
	Hill-Rom Holdings, Inc. (the "Company," "Hill-Rom," "we," "us," or "our") was incorporated on August 7, 1969 in the State of Indiana and is headquartered in Batesville, Indiana. We are a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Our comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings, to enhance the safety and quality of patient care.
	Basis of Presentation and Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Hill-Rom and its subsidiaries.  All subsidiaries are wholly-owned as of September 30, 2013.  During the first quarter of our fiscal 2011, we acquired the remaining 40 percent noncontrolling interest in a former joint venture (Note 2).  Intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Examples of such estimates include our accounts receivable reserves (Note 1), accrued warranties (Note 1), the impairment of intangibles and goodwill (Note 3), investments (Note 5), income taxes (Note 9) and commitments and contingencies (Note 13), among others.
	Cash and Cash Equivalents
	We consider investments in marketable securities and other highly liquid instruments with a maturity of three months or less at date of purchase to be cash equivalents. Investments which have no stated maturity are also considered cash equivalents. All of our marketable securities may be freely traded.
	Investment Securities
	At September 30, 2013, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").  These securities are generally insured through the U.S. government's Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.  These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Income (Loss) ("AOCL").
	We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria. The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery. If there is a decline in a security's net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.  The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.
	See Note 5 for further details on our fair value measurements.
	Trade Accounts Receivable
	Trade accounts receivable are recorded at the invoiced amount and do not bear interest, unless the transaction is an installment sale with payment terms exceeding one year. Reserves for uncollectible accounts represent our best estimate of the amount of probable credit losses and collection risk in our existing accounts receivable. We determine such reserves based on historical write-off experience by industry and reimbursement platform. Receivables are generally reviewed on a pooled basis based on historical collection experience for each reimbursement and receivable type. Receivables for capital sales transactions are also reviewed individually for collectability. Account balances are charged against the allowance when we believe it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers. If circumstances change, such as higher than expected claims denials, payment defaults, changes in our business composition or processes, adverse changes in general economic conditions, unfavorable impacts of austerity measures initiated by some governmental authorities, instability or disruption of credit markets, or an unexpected material adverse change in a major customer's or payor's ability to meet its obligations, our estimates of the realizability of trade receivables could be reduced by a material amount.
	Within rental revenue, the domestic third-party payors' reimbursement process requires extensive documentation, which has had the effect of slowing both the billing and cash collection cycles relative to the rest of the business, and therefore, increasing total accounts receivable. Because of the extensive documentation required and the requirement to settle a claim with the primary payor prior to billing the secondary and/or patient portion of the claim, the collection period for a claim in a portion of our business may, in some cases, be extended.
	We generally hold our trade accounts receivable until they are paid. Certain long-term receivables are occasionally sold to third parties; however, any recognized gain or loss on such sales has historically not been material.
	Inventories
	Inventories are valued at the lower of cost or market. Inventory costs are determined by the last-in, first-out ("LIFO") method for approximately 47 and 44 percent of our inventories at September 30, 2013 and 2012. Costs for other inventories have been determined principally by the first-in, first-out ("FIFO") method. Inventories consist of the following:
			30-Sep
			2013			2012
	Finished products		$	66.3		$	71.8
	Work in process			5.8			6.4
	Raw materials			46.2			48.7
	Total		$	118.3		$	126.9
	If the FIFO method of inventory accounting, which approximates current cost, had been used for all inventories, they would have been approximately $3.2 million and $3.1 million higher than reported at September 30, 2013 and 2012.
	Property, Plant and Equipment
	Property, plant and equipment is recorded at cost and depreciated over the estimated useful life of the assets using principally the straight-line method. Ranges of estimated useful lives are as follows:
			Useful Life
	Land improvements		6 - 15 years
	Buildings and building equipment		10 - 40 years
	Machinery and equipment		3 - 10 years
	Equipment leased to others		2 -10 years
	When property, plant and equipment is retired from service or otherwise disposed of, the cost and related amount of depreciation or amortization are eliminated from the asset and accumulated depreciation accounts. The difference, if any, between the net asset value and the proceeds on sale are charged or credited to income. Total depreciation expense for fiscal years 2013, 2012 and 2011 was $71.2 million, $73.9 million and $74.3 million. The major components of property and the related accumulated depreciation were as follows:
			30-Sep
			2013						2012
						Accumulated						Accumulated
			Cost			Depreciation			Cost			Depreciation
	Land and land improvements		$	14		$	2.1		$	16.1		$	4.4
	Buildings and building equipment			143.1			84.6			142.6			85.8
	Machinery and equipment			288			198.8			276.3			187.6
	Equipment leased to others			376.6			301.9			399.9			307
	Total		$	821.7		$	587.4		$	834.9		$	584.8
	Intangible Assets
	Intangible assets are stated at cost and consist predominantly of goodwill, software, patents, trademarks, and acquired customer relationship assets. With the exception of goodwill and certain trademarks, our intangible assets are amortized on a straight-line basis over periods generally ranging from 3 to 20 years.
	We assess the carrying value of goodwill and non-amortizable intangibles annually, during the third quarter of each fiscal year, or more often if events or changes in circumstances indicate there may be impairment. Goodwill is allocated among the reporting units based on the relative fair value of those units.
	The majority of our goodwill and many of our intangible assets are not deductible for income tax purposes. A summary of intangible assets and the related accumulated amortization and impairment losses follows:
			30-Sep
			2013						2012
						Amortization						Amortization
			Cost			and Impairment			Cost			and Impairment
	Goodwill		$	815.6		$	472.8		$	808		$	472.8
	Software			164.6			135.9			163.2			123.7
	Other			336.4			112.4			334.4			83.1
	Total		$	1,316.60		$	721.1		$	1,305.60		$	679.6
	Amortization expense for fiscal years 2013, 2012 and 2011 was $45.6 million, $37.8 million and $29.6 million. Amortization expense for all intangibles is expected to approximate the following for each of the next five fiscal years and thereafter:
			Amount
	2014		$	39.8
	2015		$	36.4
	2016		$	29.2
	2017		$	20.6
	2018		$	17
	2019 and beyond		$	76.8
Software consists mainly of capitalized costs associated with internal use software, including applicable costs associated with the implementation/upgrade of our Enterprise Resource Planning system. In addition, software includes capitalized development costs for software products to be sold. The net book value of computer software costs, included within intangible assets, was $28.7 million and $39.5 million at September 30, 2013 and 2012. Capitalized software costs are amortized on a straight-line basis over periods ranging from three to ten years. Software amortization expense approximated $17.8 million, $20.7 million and $19.1 million for fiscal years 2013, 2012 and 2011, and is included in the total intangibles amortization presented earlier.
Guarantees
We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  During fiscal 2013, we have recognized charges of $12.2 million to cover the estimated costs associated with field corrective actions on five different product lines.  We also recognized a charge of $16.0 million for a fiscal 2012 field corrective action on one of our med-surg product lines.  These field corrective actions do not limit the manufacture, sale or ongoing use of these products.
A reconciliation of changes in our warranty reserve is as follows:
		2013			2012			2011
Balance at October 1		$	42.2		$	17.8		$	15.8
Provision for warranties during the period			29.2			31.8			17
Warranty reserves acquired			(2.6	)		9.7			-
Warranty claims incurred during the period			(30.7	)		(17.1	)		(15.0	)
Balance at September 30		$	38.1		$	42.2		$	17.8
In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.
In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of our commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.
Retirement Plans
We sponsor retirement and postretirement plans covering select employees. Expense recognized in relation to these defined benefit retirement plans and the postretirement health care plan in the U.S. is based upon actuarial valuations and inherent in those valuations are key assumptions including discount rates, and where applicable, expected returns on assets, projected future salary rates and projected health care cost trends. The discount rates used in the valuation of our defined benefit pension and postretirement plans are evaluated annually based on current market conditions. In setting these rates we utilize long-term bond indices and yield curves as a preliminary indication of interest rate movements, and then make adjustments to the respective indices to reflect differences in the terms of the bonds covered under the indices in comparison to the projected outflow of our obligations. Our overall expected long-term rate of return on pension assets is based on historical and expected future returns, which are inflation adjusted and weighted for the expected return for each component of the investment portfolio. Our rate of assumed compensation increase is also based on our specific historical trends of wage adjustments.
We account for our defined benefit pension and other postretirement plans by recognizing the funded status of a benefit plan in the statement of financial position. We also recognize in Accumulated Other Comprehensive Income (Loss) certain gains and losses that arose during the period. See Note 6 for key assumptions and further discussion related to our pension and postretirement plans.
Environmental Liabilities
Expenditures that relate to an existing condition caused by past operations, and which do not contribute to future revenue generation, are expensed. A reserve is established when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These reserves are determined without consideration of possible loss recoveries from third parties.
Specific costs included in environmental expense and reserves include site assessment, development of a remediation plan, clean-up costs, post-remediation expenditures, monitoring, fines, penalties and legal fees. Reserve amounts represent the expected undiscounted future cash outflows associated with such plans and actions.
Self Insurance
We are also involved in other possible claims, including product and general liability, workers' compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions ranging from $25 thousand to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower.  We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Consolidated Balance Sheets.
Revenue Recognition - Sales and Rentals
Net revenue reflects gross revenue less sales discounts and allowances and customer returns for product sales and rental revenue reserves. Revenue is evaluated under the following criteria and recognized when each is met:
	•	Evidence of an arrangement: An agreement with the customer reflecting the terms and conditions to deliver products or services serves as evidence of an arrangement.
	•	Delivery: For products, delivery is considered to occur upon receipt by the customer and the transfer of title and risk of loss. For rental services, delivery is considered to occur when the services are rendered.
	•	Fixed or determinable price: The sales price is considered fixed or determinable if it is not subject to refund or adjustment.
	•	Collection is deemed probable: At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
As a general interpretation of the above guidelines, revenue for health care and surgical products are generally recognized upon delivery of the products to the customer and their assumption of risk of loss and other risks and rewards of ownership. Local business customs and non-standard sales terms can sometimes result in deviations to this normal practice in certain instances; however, in no case is revenue recognized prior to the transfer of risk of loss and rewards of ownership.
For non-invasive therapy products and medical equipment management services, the majority of product offerings are rental products for which revenue is recognized consistent with the rendering of the service and use of products. For The Vest® product, revenue is generally recognized at the time of receipt of authorization for billing from the applicable paying entity as this serves as evidence of the arrangement and sets a fixed or determinable price.
For health care products and services aimed at improving operational efficiency and asset utilization, various revenue recognition techniques are used, depending on the offering. Arrangements to provide services, routinely under separately sold service and maintenance contracts, result in the deferral of revenue until specified services are performed. Service contract revenue is generally recognized ratably over the contract period, if applicable, or as services are rendered. Product-related goods are generally recognized upon delivery to the customer.
Revenue is presented in the Statements of Consolidated Income net of certain discounts and sales adjustments. For product sales, we record reserves resulting in a reduction of revenue for contractual discounts, as well as price concessions and product returns. Likewise, rental revenue reserves, reflecting contractual and other routine billing adjustments, are recorded as a reduction of revenue. Reserves for revenue are estimated based upon historical rates for revenue adjustments.
Taxes Collected from Customers and Remitted to Governmental Units
Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes, and value added taxes, are accounted for on a net (excluded from revenue and cost) basis.
Cost of Revenue
Cost of goods sold for capital sales consists primarily of purchased material costs, fixed manufacturing expense, variable direct labor, overhead costs and costs associated with the distribution and delivery of products to our customers. Rental expenses consist of costs associated directly with rental revenue, including depreciation, maintenance, logistics and service center facility and personnel costs.
Research and Development Costs
Research and development costs are expensed as incurred. Costs were $70.2 million, $66.9 million and $63.8 million for fiscal years 2013, 2012 and 2011.
In addition, certain software development technology costs are capitalized as intangibles and are amortized over a period of three to five years once the software is ready for its intended use. The amount capitalized during fiscal years 2013, 2012 and 2011 was approximately $2.4 million, $2.3 million and $2.1 million.
Advertising Costs
Advertising costs are expensed as incurred. Costs were $7.4 million, $4.4 million and $4.0 million for fiscal years 2013, 2012 and 2011.
Comprehensive Income
We include the net-of-tax effect of unrealized gains or losses on our available-for-sale securities, foreign currency translation adjustments and pension or other defined benefit postretirement plans' actuarial gains or losses and prior service costs or credits in comprehensive income.
The composition of accumulated other comprehensive (loss) income, net of applicable taxes, is as follows:
		30-Sep
		2013			2012			2011
Available-for-sale securities and hedges		$	(0.3	)	$	(0.4	)	$	(0.9	)
Foreign currency translation adjustment			(4.6	)		(17.2	)		(15.7	)
Items not yet recognized as a component of net periodic pension
and postretirement healthcare costs			(30.8	)		(60.4	)		(62.4	)
Total		$	(35.7	)	$	(78.0	)	$	(79.0	)
Foreign Currency Translation
The functional currency of foreign operations is generally the local currency in the country of domicile. Assets and liabilities of foreign operations are primarily translated into U.S. dollars at year-end rates of exchange and the income statements are translated at the average rates of exchange prevailing during the year. Adjustments resulting from translation of the financial statements of foreign operations into U.S. dollars are excluded from the determination of net income, but included as a component of Accumulated Other Comprehensive Income (Loss). Foreign currency gains and losses resulting from foreign currency transactions are included in our results of operations and are not material.
Stock-Based Compensation
We account for stock-based compensation under fair value provisions. Stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options and other performance-based stock awards on the date of grant, we utilize a Binomial model. Inherent in this model are assumptions related to a volatility factor, expected life, risk-free interest rate, dividend yield and expected forfeitures. The risk-free interest rate is based on factual data derived from public sources. The volatility factor, expected life, dividend yield and expected forfeiture assumptions require judgment utilizing historical information, peer data and future expectations. Deferred stock (also known as restricted stock units ("RSUs")) is measured based on the fair market price of our common stock on the date of grant, as reported by the New York Stock Exchange, multiplied by the number of units granted.  See Note 7 for further details.
Income Taxes
The Company and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions. Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit. See Note 9 for further details.
Derivative Instruments and Hedging Activity
We use derivative financial instruments to manage the economic impact of fluctuations in currency exchange and interest rates. Derivative financial instruments related to currency exchange rates include forward purchase and sale agreements which generally have terms no greater than 15 months. Additionally, interest rate swaps are used to convert some or all of our long term debt to either a fixed or variable rate.
Derivative financial instruments are recognized on the Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair value of derivatives are recorded each period in the Statement of Consolidated Income or Accumulated Other Comprehensive Income (Loss), depending on whether a derivative is designated and considered effective as part of a hedge transaction, and if it is, the type of hedge transaction.  Gains and losses on derivative instruments reported in Accumulated Other Comprehensive Income (Loss) are subsequently included in the Statement of Consolidated Income in the periods in which earnings are affected by the hedged item. These activities have not had a material effect on our financial position or results of operations for the periods presented herein.
Recently Issued Accounting Guidance
In December 2011, the FASB issued a standard increasing disclosure about offsetting assets and liabilities.  For financial instruments and derivative instruments, the standard requires disclosure of the gross amounts of recognized assets and liabilities, the amounts offset on the balance sheet, and the amounts subject to the offsetting requirements but not offset on the balance sheet. In January 2013, the FASB issued updated guidance which clarified that the 2011 amendment to the balance sheet offsetting standard does not cover transactions that are not considered part of the guidance for derivatives and hedge accounting. The standard is effective for fiscal 2014 and is to be applied retrospectively. The adoption of this standard is not expected to have a significant impact on our Consolidated Financial Statements.
In July 2012, the FASB issued an amendment to the authoritative guidance on the annual impairment test on indefinite-lived intangible assets.  The amendment provides the option to first assess qualitative factors to determine whether it is necessary to perform the current quantitative test.  If, as a result of the qualitative assessment, it is determined it is more likely than not that the fair value of an intangible asset is less than its carrying amount, the quantitative impairment test is required.  Otherwise, no further testing is required.  The amendment will be effective beginning October 1, 2013, however early adoption is permitted.  We will consider applying this guidance in connection with future annual intangible impairment tests.  We do not expect this to have a material impact on our Consolidated Financial Statements
In February 2013, an accounting standards update was issued that amends the reporting of amounts reclassified out of accumulated other comprehensive income. This standard does not change the current requirements for reporting net income or other comprehensive income in the financial statements. However, the guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component, either on the face of the financial statement where net income is presented or in the notes to the financial statements. The standard is effective for fiscal 2014 and is to be applied prospectively. The adoption of this standard is not expected to have a significant impact on our Consolidated Financial Statements.

ACQUISITIONS

ACQUISITIONS	12 Months Ended
	Sep. 30, 2013
ACQUISITIONS [Abstract]	'
ACQUISITIONS	'
	NOTE 2. ACQUISITIONS
	Aspen Surgical
	On July 23, 2012, we completed a stock purchase agreement with the stockholders and optionholders of Aspen Surgical Products Holding, Inc. ("Aspen Surgical") to acquire the entire equity interest in Aspen Surgical.  Aspen Surgical provides a portfolio of well-established surgical consumable and specialty medical products, focused on improving the safety of patients and health care professionals. The product lines include market leading Bard-Parker® conventional and safety scalpels and blades, Colby™ fluid collection products, Richard-Allan™ specialty needles, a variety of other operating room disposables and instrument care products as well as wound care dressings. The acquisition of Aspen Surgical further develops our surgical business, adding a portfolio of consumable products and expanding our position in the North American and European surgical markets.
	The purchase price for Aspen Surgical was $402.2 million ($399.8 million net of cash acquired), which was reduced to $401.2 million, resulting from a $1.0 million purchase price adjustment in fiscal 2013.   We funded the transaction with a combination of cash on hand and borrowings under the revolving credit facility.  The results of Aspen Surgical are included in the Consolidated Financial Statements since the date of acquisition.
	Throughout fiscal 2013, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.  The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.
		Amount
	Inventory	$	25.6
	Other current assets		19.7
	Property, plant, and equipment		24.6
	Goodwill		220.1
	Trade name (Indefinite Lived)		29
	Trade name (15-year weighted-average useful life)		4.6
	Customer relationships (13-year weighted-average useful life)		121.9
	Technology (10-year weighted-average useful life)		9.1
	Other noncurrent assets		1.6
	Current liabilities		(14.0	)
	Deferred tax liability		(41.0	)
	Total purchase price	$	401.2
	Goodwill was allocated entirely to our Surgical and Respiratory Care segment and is not deductible for tax purposes.
	Our total revenue on an unaudited proforma basis, as if the Aspen Surgical acquisition had been consummated at the beginning of our 2011 fiscal year, would have been higher by approximately $92.3 million and $118.1 million for the years ended September 30, 2012 and 2011.  Net income, on an unaudited proforma basis, would have been higher by approximately $5.7 million and $11.1 million for the years ended September 30, 2012 and 2011 and earnings per diluted share would have been higher by $0.09 and $0.17 for the years ended September 30, 2012 and 2011.  The unaudited pro forma results are based on the Company's historical financial statements and those of the Aspen Surgical business and do not necessarily indicate the results of operations that would have resulted had the acquisition been completed at the beginning of the comparable period presented and are not indicative of the results of operations in future periods.
	Völker
	On February 13, 2012, we acquired the Germany-based Völker group ("Völker").   Völker is a leading manufacturer of long-term care and acute care bed frames, surfaces and furniture in Europe and around the world.  This transaction is expected to strengthen the Company's channels and product offerings in Europe, and furthers our objective of completing strategically relevant and value-enhancing acquisitions.  The complementary Völker products will also further develop the Company's global portfolio, accelerate international expansion, and leverage existing sales channels and customer relationships.  The purchase price for Völker was $80.7 million ($77.0 million net of cash acquired), which was reduced to $76.7 million, resulting from a $4.0 million purchase price adjustment, $1.2 million of which was recorded as a receivable from the seller as of September 30, 2013.  The results of Völker are included in the Consolidated Financial Statements since the date of acquisition.
	During the fourth quarter of 2012, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.  During the second and fourth quarters of 2013, we made additional adjustments to the opening balance sheet related to the finalization of certain liabilities existing at the date of acquisition.  The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.
		Amount
	Goodwill	$	32.9
	Trade name (7-year useful life)		12.3
	Customer relationships (8-year weighted average useful life)		17.5
	Net assets acquired		24.6
	Deferred tax liability		(10.6	)
	Total purchase price	$	76.7
	Goodwill is not deductible for tax purposes and was allocated entirely to our International segment.
	Our total revenue on an unaudited proforma basis, as if the Völker acquisition had been consummated at the beginning of our 2011 fiscal year, would have been higher by approximately $49.9 million and $117.0 million for the years ended September 30, 2012 and 2011.  The impact to net income on an unaudited proforma basis would not have been significant to our financial results for those years.
	Encompass Joint Venture
	On November 9, 2009, we entered into a joint venture with Encompass Group, LLC ("Encompass Group"), a leader in health care textiles and therapeutic and prevention surfaces, to form Encompass TSS, LLC ("Encompass").  This joint venture included contributed former assets of Encompass Therapeutic Support Systems ("ETSS"), a division of Encompass Group and was 60 percent owned by us and 40 percent owned by Encompass Group.  Encompass Group, through its ETSS business unit, traditionally focused on providing surface replacement systems.  For our 60 percent ownership interest in the Encompass JV we paid $7.5 million to Encompass Group, contributed cash and entered into license and distribution agreements with Encompass JV.
	The following table summarizes the fair value of the assets acquired and liabilities assumed at the date of formation.
		Amount
	Goodwill	$	8
	Trade Name (7-year useful life)		1.5
	Customer relationships  (7-year useful life)		7.7
	Technology (5-year useful life)		2.4
	Net liabilities assumed		(0.7	)
	Noncontrolling interest		(7.5	)
	Additional paid-in-capital		(3.9	)
	Total purchase price	$	7.5
	The Encompass JV agreements contained both a put option for Encompass Group and a call option for us, requiring or allowing us to purchase the remaining 40 percent interest based on predetermined earnings multiples.  Changes to the value of the put were accreted to noncontrolling interest in our Consolidated Balance Sheet with the offset being recorded as a component of retained earnings.
	The goodwill of $8.0 million arising from the Encompass JV consisted largely of the synergies created from combining ETSS's focus on customer replacement surfaces with our platform brands.  The goodwill is deductible for tax purposes and was allocated entirely to our North America segment.
	On November 30, 2010, we exercised our call option and purchased the remaining 40 percent of Encompass for $10.6 million, plus a variable earn-out with a minimum of $1.2 million and a maximum of $1.6 million per year over five years.  We have a total of $3.0 million accrued in other current liabilities and other long-term liabilities on our Consolidated Balance Sheet at September 30, 2013 related to the earn-out.

IMPAIRMENT_OF_GOODWILL_AND_OTH

IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES	12 Months Ended
	Sep. 30, 2013
IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES [Abstract]	'
IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES	'
	NOTE 3. IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES
	We perform an impairment assessment on goodwill and other indefinite-lived intangibles on an annual basis during our third fiscal quarter, or more often if events or circumstances indicate there may be impairment.  The assessments during the third quarter of 2013, 2012 and 2011 indicated that there was no impairment.
	During the second quarter of fiscal 2012, we were required to perform an interim impairment test on a trade name, triggered by strategic changes in how the asset would be utilized on a go forward basis.  The fair value of the trade name was calculated with assistance from a third party valuation firm and resulted in a charge of $8.0 million, as disclosed in Note 8.  The relief from royalty approach was used by applying a royalty rate to future revenue projections and then a discount rate was applied.  All Hill-Rom-specific data and analytics, including estimates and assumptions, used in the valuation prepared by the third party valuation firm were either prepared or validated by us.  Management takes full responsibility for this data and the ultimate results of the valuation work.  The fair value measurement was classified as Level 3, as described in Note 5.
	As discussed in Note 11, we operate in three reportable business segments.  Goodwill impairment testing is performed at the reporting unit level, which is one level below a reportable business segment.  We have determined that we have nine reporting units.  Goodwill is assigned to reporting units at the date the goodwill is initially recorded and has been reallocated as necessary based on the restructuring of reporting units over time.  Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or organically grown, are available to support the value of the goodwill.
	A 10 percent reduction in the fair value of any of our reporting units would not result in an impairment charge.
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and		International			Total
					Respiratory Care
	Balances at September 30, 2011:
	Goodwill		383			56.2		120.8			560
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2011		24.9			56.2		6.1			87.2
	Changes in Goodwill during the period:
	Goodwill related to acquisition		-			215.3		35.1			250.4
	Currency translation effect		-			-		(2.4	)		(2.4	)
	Balances at September 30, 2012:
	Goodwill		383			271.5		153.5			808
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2012		24.9			271.5		38.8			335.2
	Changes in Goodwill during the period:
	Goodwill related to acquisition		-			4.8		(1.9	)		2.9
	Currency translation effect		-			2.7		2			4.7
	Balances at September 30, 2013:
	Goodwill		383			279		153.6			815.6
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2013	$	24.9		$	279	$	38.9		$	342.8
	During fiscal 2013, we recorded net adjustments to goodwill of $4.8 million related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012 and ($1.9) million related to the Völker acquisition completed during the second quarter of fiscal 2012.  See Note 2 for further details.
	During the second quarter of fiscal 2012, we acquired Völker and recorded goodwill on the acquisition of $34.8 million.  During the fourth quarter of fiscal 2012, we acquired Aspen Surgical and recorded goodwill on the acquisition of $215.3 million.  See Note 2 for further details.
	Indefinite-lived intangible assets
	We have various indefinite-lived intangible assets representing trade names with a carrying value of $32.9 million at both September 30, 2013 and September 30, 2012.  Testing for impairment must be performed annually, or on an interim basis upon the occurrence of a triggering event or change in circumstances that would more likely than not reduce the fair value of an indefinite-lived intangible asset below its carrying amount.  The annual evaluation of indefinite-lived intangible assets performed during the third fiscal quarter of 2013, 2012, and 2011 did not result in impairment.

FINANCING_AGREEMENTS

FINANCING AGREEMENTS	12 Months Ended
	Sep. 30, 2013
FINANCING AGREEMENTS [Abstract]	'
FINANCING AGREEMENTS	'
	NOTE 4. FINANCING AGREEMENTS
	Total debt consists of the following:
		Years Ended September 30
		2013		2012
	Outstanding finance credit lines	$	-	$	0.2
	Revolving credit facility		70		105
	Term loan current portion		11.2		10
	Term loan long-term portion		176.2		187.5
	Unsecured 7.00% debentures due on February 15, 2024		19.6		19.6
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.2		0.6
	Total debt		307		352.7
	Less current portion of debt		81.2		115.2
	Total long-term debt	$	225.8	$	237.5
	The following table summarizes the scheduled maturities of long-term debt for fiscal years 2014 through 2018:
		Term Loan
	2014	$	11.2
	2015	$	16.2
	2016	$	20
	2017	$	140
	2018	$	-
	We have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.
	Unsecured debentures outstanding at September 30, 2013 have fixed rates of interest.  We have deferred gains included in the amounts above from the termination of previous interest rate swap agreements, and those deferred gains amounted to less than $1 million at both September 30, 2013 and September 30, 2012.  The deferred gains on the termination of the swaps are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2025, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates on the debt.
	During the fourth quarter of fiscal 2012, we entered into a credit facility.  The credit facility provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.  It is to be used for general corporate purposes, including financing permitted acquisitions.  The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.  All amounts due under the credit facility mature upon expiration on August 24, 2017.  The term loans will amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  The credit facility replaced in its entirety our previous $500.0 million credit agreement entered in 2008.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that for fiscal 2013 were under 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The covenants, among other things, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  The proceeds of the five-year facility shall be used, as needed: (i) for working capital, capital expenditures, and other lawful corporate purposes; and (ii) to finance acquisitions.
	As of September 30, 2013, we had outstanding borrowings of $70.0 million and undrawn letters of credit of $5.3 million under the facility, leaving $424.7 million of available borrowing capacity.  The outstanding balance on the term loan was $187.4 million at September 30, 2013, of which $11.2 million is recognized as the current portion of the balance due.
	The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value. The estimated fair values of our long-term unsecured debentures were $52.5 million and $56.2 million at September 30, 2013 and 2012, and were based on observable inputs such as quoted prices in markets that are not active.  The estimated fair value of our term loan was $185.5 million and $197.5 million based on quoted prices for similar liabilities at September 30, 2013 and 2012.  The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 5.
	The Company is exposed to market risk from fluctuations in interest rates.  The Company sometimes manages its exposure to interest rate fluctuations through the use of interest rate swaps (cash flow hedges).  As of September 30, 2013, we had one interest rate swap agreement with a notional amount of $135.0 million to hedge the variability of cash flows associated with a portion of the term loan variable interest rate payments for the period of January 2014 to August 2017.  The interest rate swap has been designated as a cash flow hedge.  The fair value as of September 30, 2013 was less than $0.1 million. We did not have any interest rate swap agreements in effect during fiscal 2012 or 2011.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Sep. 30, 2013
FAIR VALUE MEASUREMENTS [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	NOTE 5. FAIR VALUE MEASUREMENTS
	Fair value measurements are classified and disclosed in one of the following three categories:
		·	Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.
		·	Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
		·	Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk). Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.
	The following table summarizes our financial assets and liabilities included in our Consolidated Balance Sheets, measured at fair value on a recurring basis:
						Quoted Prices in		Significant Other		Significant
						Active Markets for		Observable		Unobservable
			Balance at			Identical Assets		Inputs		Inputs
			30-Sep-13			(Level 1)		(Level 2)		(Level 3)
	Cash and cash equivalents		$	127.4		$	127.4	$	-	$	-
	Available-for-sale marketable securities			7.3			-		-		7.3
	Total assets at fair value		$	134.7		$	127.4	$	-	$	7.3
						Quoted Prices in		Significant Other		Significant
						Active Markets for		Observable		Unobservable
			Balance at			Identical Assets		Inputs		Inputs
			30-Sep-12			(Level 1)		(Level 2)		(Level 3)
	Cash and cash equivalents		$	84.3		$	84.3	$	-	$	-
	Available-for-sale marketable securities			7.3			-		-		7.3
	Total assets at fair value		$	91.6		$	84.3	$	-	$	7.3
	The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practicable to estimate that value.
	At September 30, 2013 and 2012, we had $7.3 million of AAA rated investment securities which consisted primarily of student loan auction rate securities.  While we continue to earn interest on the ARS at the contractual rate, these investments are not currently being bought and sold in an active market and therefore do not have readily determinable market values.  At September 30, 2013 and 2012, our investment advisors provided a valuation based on unobservable inputs for the ARS.  The investment advisors utilized a discounted cash flow approach (an "income approach") to arrive at this valuation, which was corroborated by separate and comparable discounted cash flow analysis prepared by us.  The assumptions used in preparing the discounted cash flow model include estimates of interest rates, timing and amount of cash flows, credit spread related yield and illiquidity premiums, and expected holding periods of the ARS.  These assumptions are volatile and subject to change as the underlying sources of these assumptions and market conditions change.  See below for a reconciliation of the beginning to ending balances of these assets and the related change in the fair value of these assets during fiscal 2013.
	Currently, we intend, and believe we have the ability to hold these assets until market conditions are more favorable.  If current market conditions do not improve or worsen, the result could be further realized or unrealized losses.
	The following table presents the activity related to our ARS during the fiscal year.
			Available-For-Sale			AOCL		(Gain)/Loss
	Balance at October 1, 2012		$	7.3		$	0.5	$	-
	Change in fair value			-			-		-
	Sales or redemptions			-			-		-
	Balance at September 30, 2013		$	7.3		$	0.5	$	-
	The components of the change in our unrealized gains (losses) were as follows:
				Years Ended September 30
				2013	2012		2011
	Unrealized gains (losses) on available-for sale securities:
		Unrealized holding gains (losses) arising during period, net-of-tax		$               -	$              0.7		$            (0.2)
		Less:  Reclassification adjustment for losses (gains) realized in net income, net-of-tax		-	0.1		-
	Net change in unrealized gains (losses), net-of-tax			$               -	$              0.8		$            (0.2)
	For the fiscal years ended September 30, 2013, 2012 and 2011, we recognized income on our investments of $0.6 million, $1.3 million and $2.0 million, which did not include any impairments.
	Financial instruments not carried at fair value consist of our debt.  See further fair value discussion in Note 4.
	The carrying amounts of current assets and liabilities approximate fair value because of the short maturity of those instruments.

RETIREMENT_AND_POSTRETIREMENT_

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS	12 Months Ended
	Sep. 30, 2013
RETIREMENT AND POSTRETIREMENT BENEFIT PLANS [Abstract]	'
RETIREMENT AND POSTRETIREMENT BENEFIT PLANS	'
	NOTE 6. RETIREMENT AND POSTRETIREMENT BENEFIT PLANS
	Our retirement plans consist of defined benefit plans, a postretirement healthcare plan, and defined contribution savings plans. Plans cover certain employees both in and outside of the U.S.
	Retirement Plans
	We sponsor four defined benefit plans. Those plans include a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan, and two defined benefit retirement plans covering employees in Germany and France.    Benefits for such plans are based primarily on years of service and the employee's level of compensation during specific periods of employment. We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time. All of our plans have a September 30th measurement date.
	Effect on Operations
	The components of net periodic benefit cost for our defined benefit retirement plans were as follows:
		Years Ended September 30
		2013				2012			2011
	Service cost	$	6.1			$	5.5		$	5.2
	Interest cost		13.2				13.3			13.2
	Expected return on plan assets		(15.9	)			(16.7	)		(16.7	)
	Amortization of unrecognized prior service cost, net		0.6				0.6			0.6
	Amortization of net loss		7.8				6.1			4
	Net periodic benefit cost	$	11.8			$	8.8		$	6.3
	Obligations and Funded Status
	The change in benefit obligations, plan assets and funded status, along with amounts recognized in the Consolidated Balance Sheets for our defined benefit retirement plans were as follows:
		30-Sep
		2013				2012
	Change in benefit obligation:
	Benefit obligation at beginning of year	$	327.4			$	295.9
	Service cost		6.1				5.5
	Interest cost		13.2				13.3
	Actuarial (gain) loss		(41.1	)			21.7
	Benefits paid		(9.1	)			(8.5	)
	Acquisitions		-				0.1
	Amendments		0.6				-
	Exchange rate loss (gain)		0.8				(0.6	)
	Benefit obligation at end of year		297.9				327.4
	Change in plan assets:
	Fair value of plan assets at beginning of year		246.8				217.3
	Actual return on plan assets		15.7				37
	Employer contributions		1				1
	Benefits paid		(9.1	)			(8.5	)
	Fair value of plan assets at end of year		254.4				246.8
	Funded status and net amounts recognized	$	(43.5	)		$	(80.6	)
	Amounts recorded in the Consolidated Balance Sheets:
	Accrued pension benefits, current portion	$	(0.2	)		$	(0.1	)
	Accrued pension benefits, long-term		(43.3	)			(80.5	)
	Net amount recognized	$	(43.5	)		$	(80.6	)
	In addition to the amounts above, net actuarial losses of $51.3 million and prior service costs of $2.4 million, less an applicable aggregate tax effect of $20.0 million are included as components of Accumulated Other Comprehensive Income (Loss) at September 30, 2013. At September 30, 2012, net actuarial losses of $100.0 million and prior service costs of $2.4 million, less an applicable aggregate tax effect of $38.7 million, were included as components of Accumulated Other Comprehensive Income (Loss).
	The estimated net actuarial loss and prior service cost for our defined benefit retirement plans that will be amortized from Accumulated Other Comprehensive Income (Loss) into net periodic benefit cost over the next fiscal year are $3.2 million and $0.6 million.
	Accumulated Benefit Obligation
	The accumulated benefit obligation for all defined benefit pension plans was $278.8 million and $302.4 million at September 30, 2013 and 2012. Selected information for our plans, including plans with accumulated benefit obligations exceeding plan assets, was as follows:
		30-Sep
		2013										2012
		PBO				ABO			Plan Assets			PBO		ABO		Plan Assets
	Supplemental executive plan	$	3.9			$	3.7		$	-		$	4.4	$	4.2	$	-
	Master plan		279.2				261.7			254			309.5		285.7		246.4
	German plan		10.4				10.4			-			10.4		10.4		-
	French plan		4.4				3			0.4			3.1		2.1		0.4
		$	297.9			$	278.8		$	254.4		$	327.4	$	302.4	$	246.8
	Actuarial Assumptions
	The weighted average assumptions used in accounting for our domestic pension plans were as follows:
		2013			2012			2011
	Weighted average assumptions to determined benefit
	obligations at the measurement date:
	Discount rate for obligation	5.00%			4.10%			4.60%
	Rate of compensation increase	3.30%			3.30%			3.50%
	Weighted average assumptions to determined benefit
	cost for the year:
	Discount rate for expense	4.10%			4.60%			5.10%
	Expected rate of return on plan assets	7.00%			7.50%			7.50%
	Rate of compensation increase	3.30%			3.50%			3.50%
The discount rates used in the valuation of our defined benefit pension plans are evaluated annually based on current market conditions. In setting these rates we utilize long-term bond indices and yield curves as a preliminary indication of interest rate movements, and then make adjustments to the respective indices to reflect differences in the terms of the bonds covered under the indices in comparison to the projected outflow of our pension obligations. The overall expected long-term rate of return is based on historical and expected future returns, which are inflation adjusted and weighted for the expected return for each component of the investment portfolio, as well as taking into consideration economic and capital market conditions. The rate of assumed compensation increase is also based on our specific historical trends of past wage adjustments.  The weighted average assumptions used for our international plans are lower than our domestic plan assumptions and do not significantly affect the consolidated net benefit obligation or net periodic benefit cost balances.
Plan Assets
The weighted average asset allocations of our master defined benefit retirement plan at September 30, 2013 and 2012, by asset category, along with target allocations, are as follows:
	2013			2012			2013		2012
	Target			Target			Actual		Actual
	Allocation			Allocation			Allocation		Allocation
Equity securities	40 - 60%			40 - 60%			57%		50%
Fixed income securities	40 - 60%			40 - 60%			43%		50%
Total							100%		100%
We have a Plan Committee that sets investment guidelines with the assistance of an external consultant. These guidelines are established based on market conditions, risk tolerance, funding requirements and expected benefit payments. The Plan Committee also oversees the investment allocation process, selects the investment managers and monitors asset performance. As pension liabilities are long-term in nature, we employ a long-term total return approach to maximize the long-term rate of return on plan assets for a prudent level of risk.  Target allocations are guidelines, not limitations, and plan fiduciaries may occasionally approve allocations above or below a target range or elect to rebalance the portfolio within the targeted range.
The investment portfolio contains a diversified portfolio of primarily equities and fixed income securities.  Securities are also diversified in terms of domestic and international securities, short- and long-term securities, growth and value styles, large cap and small cap stocks. The Plan Committee believes with prudent risk tolerance and asset diversification, the account should be able to meet its pension obligations in the future.
Trust assets are invested subject to the following policy restrictions: short-term securities must be rated A2/P2 or higher; all fixed-income securities shall have a credit quality rating "BBB" or higher; investments in equities in any one company may not exceed 10 percent of the equity portfolio.
Fair Value Measurements of Plan Assets
The following table summarizes the valuation of our pension plan assets by pricing categories:
					Quoted Prices in			Significant
					Active Markets			Other			Significant
					for Identical			Observable			Unobservable
	Balance at				Assets			Inputs			Inputs
	30-Sep-13				(Level 1)			(Level 2)			(Level 3)
Cash	$	3			$	3		$	-		$	-
Equities
US companies		101				101			-			-
International companies		41.2				41.2			-			-
Fixed income securities		108.8				59.1			49.7			-
Other		0.4				0.4			-			-
Total plan assets at fair value	$	254.4			$	204.7		$	49.7		$	-
					Quoted Prices in			Significant
					Active Markets			Other			Significant
					for Identical			Observable			Unobservable
	Balance at				Assets			Inputs			Inputs
	30-Sep-12				(Level 1)			(Level 2)			(Level 3)
Cash	$	2.3			$	2.3		$	-		$	-
Equities
US companies		87.8				87.8			-			-
International companies		34.9				34.9			-			-
Fixed income securities		121.4				64.1			57.3			-
Other		0.4				0.4			-			-
Total plan assets at fair value	$	246.8			$	189.5		$	57.3		$	-
The Level 2 fixed income securities are commingled funds valued using the net asset value ("NAV") unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund, all of which are publicly traded securities. For further descriptions of the asset Levels used in the above chart, refer to Note 5.
Cash Flows
Our U.S. qualified defined benefit plan is funded in excess of 80 percent, and therefore we expect that the plan will not be subject to the "at risk" funding requirements of the Pension Protection Act.
During 2013 and 2012, we contributed cash of $1.0 million and $1.0 million to our defined benefit retirement plans. We do not expect to contribute to our master defined benefit retirement plan in fiscal year 2014 due to the current funding level; however, minimal contributions will be required for our unfunded plans.
Estimated Future Benefit Payments
The benefit payments, which are expected to be funded through plan assets and company contributions and reflect expected future service, are expected to be paid as follows:
	Pension Benefits
2014	$	10.8
2015	$	11.6
2016	$	12.5
2017	$	13.4
2018	$	14.2
2019-2023	$	88.5
Defined Contribution Savings Plans
We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees. The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.  Company contributions to the plans are based on eligibility and employee contributions.  Expense under these plans was $15.8 million, $13.3 million and $13.0 million in fiscal years 2013, 2012 and 2011.
Postretirement Health Care Plan
In addition to defined benefit retirement plans, we also offer a domestic postretirement health care plan that provides health care benefits to qualified retirees and their dependents. The plan includes retiree cost sharing provisions and generally extends retiree coverage for medical, prescription and dental benefits beyond the COBRA continuation period to the date of Medicare eligibility. We use a measurement date of September 30 for this plan.
The postretirement health care plan reflected a credit during fiscal 2013, 2012 and 2011 of ($0.1) million, ($0.3) million and ($0.1) million.  The change in the accumulated postretirement benefit obligation was as follows:
	Years Ended September 30
	2013				2012
Change in benefit obligation:
Benefit obligation at beginning of year	$	9.6			$	9.5
Service cost		0.4				0.4
Interest cost		0.3				0.3
Actuarial (gain) loss		(0.2	)			-
Benefits paid		(0.5	)			(0.9	)
Retiree contributions		0.2				0.3
Benefit obligation at end of year	$	9.8			$	9.6
Amounts recorded in the Consolidated Balance Sheets:
Accrued benefits obligation, current portion	$	0.5			$	0.5
Accrued benefits obligation, long-term		9.3				9.1
Net amount recognized	$	9.8			$	9.6
During fiscal 2013 and 2012, we contributed $0.3 million and $0.6 million to the plan.
In addition to the amounts above, net actuarial gains of $1.8 million and prior service credits of $3.0 million, less an applicable aggregate tax effect of ($1.9) million are included as components of Accumulated Other Comprehensive Income (Loss) at September 30, 2013. At September 30, 2012, net actuarial gains of $1.6 million and prior service credits of $3.8 million, less an applicable aggregate tax effect of $2.1 million are included as components of Accumulated Other Comprehensive Income (Loss).
The estimated net actuarial gain and prior service benefit for our postretirement health care plan that will be amortized from Accumulated Other Comprehensive Income (Loss) into net periodic benefit cost over the next fiscal year are $0.0 million and ($0.9) million.
The discount rate used to determine the net periodic benefit cost for the postretirement health care plan during the fiscal year ended September 30, 2013, 2012 and 2011 was 3.3, 4.0 and 4.4 percent. The discount rate used to determine the benefit obligation as of September 30, 2013, 2012 and 2011 was 4.1, 3.3 and 4.0 percent. As of September 30, the health care-cost trend rates were assumed to decrease as follows:
	2013			2012			2011
Year 1	6.25%			6.75%			7.25%
Year 2	5.75%			6.25%			6.75%
Year 3	5.25%			5.75%			6.25%
Year 4	5.00%			5.25%			5.75%
Year 5	5.00%			5.00%			5.25%
Year 6	5.00%			5.00%			5.00%
Year 7	5.00%			5.00%			5.00%
Year 8 and beyond	5.00%			5.00%			5.00%
A one-percentage-point increase/decrease in the assumed health care cost trend rates as of September 30, 2013 would cause an increase/decrease in service and interest costs of less than $0.1 million, along with an increase/decrease in the benefit obligation of $0.9 million and $0.8 million.
We fund the postretirement health care plan as benefits are paid, and current plan benefits are expected to require net company contributions of approximately $0.5 million in fiscal 2014 and less than $1.0 million per year thereafter.

COMMON_STOCK

COMMON STOCK	12 Months Ended
	Sep. 30, 2013
COMMON STOCK [Abstract]	'
COMMON STOCK	'
	NOTE 7. COMMON STOCK
	Share Repurchases
	We repurchased 2.8 million, 1.5 million and 3.0 million shares of our common stock during fiscal years 2013, 2012 and 2011 for $92.7 million, $42.4 million and $110.0 million, respectively, in the open market.  In September 2013, the Board approved an expansion of its previously announced share repurchase authorization to a total of $190.0 million.  Prior to the September 2013 approval, which changed the authorization to a dollar value as opposed to share count, we had 1.2 million shares remaining available for purchase.  The plan does not have an expiration date and currently there are no plans to terminate this program in the future.
	Stock-Based Compensation
	We have stock-based compensation plans under which employees and non-employee directors may be granted options to purchase shares of Company common stock at the fair market value at the time of grant. In addition to stock options, we grant performance share units ("PSUs") and RSUs to certain management level employees and vested deferred stock to non-employee directors. We also offer eligible employees the opportunity to buy shares of our common stock at a discount via an Employee Stock Purchase Plan ("ESPP").  The ESPP was approved by our shareholders in fiscal 2009 and did not have a significant impact on our financial statements in any fiscal year.
	Our primary stock-based compensation program is the Stock Incentive Plan, which has been approved by our shareholders.  Under the Stock Incentive Plan, we have a total of 15.3 million authorized shares.  At September 30, 2013, 4.8 million shares were available for future grants under our stock-based compensation plans. We generally settle our stock-based awards with treasury shares. As of September 30, 2013, we had 21.8 million treasury shares available for use to settle stock-based awards.
	The following table sets forth a summary of the annual stock-based compensation cost that was charged against income for all types of awards:
			Years Ended September 30
			2013			2012				2011
	Total stock-based compensation cost (pre-tax)		$	13.5		$	11.6			$	12.2
	Total income tax benefit			(4.9	)		(4.2	)			(4.5	)
	Total stock-based compensation cost, net of tax		$	8.6		$	7.4			$	7.7
	Stock Options
	Stock options granted by our Compensation Committee under the Stock Incentive Plan are non-qualified stock options. These awards are generally granted with exercise prices equal to the average of the high and low prices of our common stock on the date of grant. They vest in equal annual installments over a three or four year period and the maximum contractual term is ten years. We use a Binomial option-pricing model to estimate the fair value of stock options, and compensation cost is recognized on a straight-line basis over the requisite service period.
	The following table sets forth the weighted average fair value per share of stock options and the related valuation assumptions used in the determination of those fair values:
			Years Ended September 30
			2013			2012				2011
	Weighted average fair value per share		$	7.91		$	9.79			$	12.31
	Valuation assumptions:
	Risk-free interest rate			0.60%			1.00%				1.20%
	Expected dividend yield			1.90%			1.40%				1.10%
	Expected volatility			40.20%			41.20%				37.30%
	Weighted average expected life			4.9 years			4.8 years				5.3 years
	The risk-free interest rate is based upon observed U.S. Treasury interest rates appropriate for the term of our employee stock options. Expected dividend yield is based on the history and our expectation of dividend payouts. For fiscal 2013, expected volatility was based on our historical stock price volatility.  In fiscal 2012 and 2011, expected volatility was based on the median of our Peer Group. The change in assumption did not have a material impact on our financial statements. Expected life represents the weighted average period the stock options are expected to remain outstanding and is a derived output of the Binomial model. The expected life of employee stock options is impacted by the above assumptions as well as the post-vesting forfeiture rate and the exercise factor used in the Binomial model. These two variables are based on the history of exercises and forfeitures for previous stock options granted by us.
	The following table summarizes transactions under our stock option plans for fiscal year 2013:
			Weighted						Weighted
			Average			Weighted			Average		Aggregate
			Number of			Average			Remaining		Intrinsic
			Shares			Exercise			Contractual		Value (1)
			(in thousands)			Price			Term		(in millions)
	Balance Outstanding at October 1, 2012			2,103		$	30.41
	Granted			501			26.94
	Exercised			(212	)		25.54
	Cancelled/Forfeited			(229	)		32.26
	Balance Outstanding at September 30, 2013			2,163		$	29.89		7.0 years		$	14.3
	Exercisable at September 30, 2013			969		$	29.63		5.5 years		$	6.8
	Options Expected to Vest			1,060		$	30.17		8.2 years		$	6.6
	-1	The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $35.83, as reported by the New York Stock Exchange on September 30, 2013. This amount, which changes continuously based on the fair value of our common stock, would have been received by the option holders had all option holders exercised their options as of the balance sheet date.
	The total intrinsic value of options exercised during fiscal years 2013, 2012 and 2011 was $1.6 million, $1.3 million and $23.3 million.
	As of September 30, 2013, there was $6.7 million of unrecognized compensation expense related to stock options granted under the Plan. This unrecognized compensation expense does not reflect a reduction for our estimate of potential forfeitures, and is expected to be recognized over a weighted average period of 1.9 years.
	Restricted Stock Units
	RSUs are granted to certain employees with fair values equal to the average of the high and low prices of our common stock on the date of grant, multiplied by the number of units granted. RSU grants are contingent upon continued employment and vest over periods ranging from one to five years. Dividends, payable in common stock equivalents, accrue on the grants and are subject to the same specified terms as the original grants, including the risk of forfeiture.
	The following table summarizes transactions for our nonvested RSUs for fiscal year 2013:
						Weighted
			Number of			Average
			Share Units			Grant Date
			(in thousands)			Fair Value
	Nonvested RSUs at October 1, 2012			307		$	30.38
	Granted			215			27.76
	Vested			(133	)		28.43
	Forfeited			(48	)		31.65
	Nonvested RSUs at September 30, 2013			341		$	29.34
	As of September 30, 2013, there was $5.9 million of total unrecognized compensation expense related to nonvested RSUs granted under the Stock Incentive Plan. This unrecognized compensation expense does not reflect a reduction for our estimate of potential forfeitures, and is expected to be recognized over a weighted average period of 2 years. The total vest date fair value of shares that vested during fiscal years 2013, 2012 and 2011 was $5.8 million, $6.8 million and $15.9 million.
	Performance Share Units
	Our Compensation Committee grants PSUs to certain employees and these awards are subject to any stock dividends, stock splits, and other similar rights inuring to common stock, but unlike our RSUs are not entitled to dividend reinvestment.  Vesting of the grants is contingent upon achievement of performance targets and corresponding service requirements.
	The fair value of the PSUs is equal to the average of the high and low prices of our common stock on the date of grant, multiplied by the number of units granted.  For PSUs with a market condition such as total shareholder return, the Monte-Carlo simulation method is used to determine fair value.   The Monte-Carlo simulation is a generally accepted statistical technique used to generate a defined number of stock price paths in order to develop a reasonable estimate of the range of our and the Peer Group's future expected stock prices.
	The following table sets forth the weighted average fair value per share for total shareholder return PSUs and the related valuation assumptions used in the determination of those fair values:
			Years Ended September 30
			2013			2012
	Weighted average fair value per share		$	19.77		$	23.26
	Valuation assumptions:
	Risk-free interest rate			0.30%			0.40%
	Expected dividend yield			0.00%			0.00%
Expected volatility			32.60%			35.60%
The basis for the assumptions listed above is similar to the valuation assumptions used for stock options, as discussed previously.
The following table summarizes transactions for our nonvested PSUs for fiscal 2013:
					Weighted
		Number of			Average
		Share Units			Grant Date
		(in thousands)			Fair Value
Nonvested PSUs as of October 1, 2012			392		$	25.4
Granted			288			19.77
Vested			-			-
Forfeited			(106	)		24.69
Nonvested PSUs at September 30, 2013			574		$	23.84
As of September 30, 2013, there was $6.2 million of unrecognized compensation expense related to PSUs granted under the Stock Incentive Plan based on the expected achievement of certain performance targets or market conditions. This unrecognized compensation expense does not reflect a reduction for our estimate of potential forfeitures, and is expected to be recognized by the end of fiscal 2014.

SPECIAL_CHARGES

SPECIAL CHARGES	12 Months Ended
	Sep. 30, 2013
SPECIAL CHARGES [Abstract]	'
SPECIAL CHARGES	'
	NOTE 8. SPECIAL CHARGES
	Over the past several years, we have placed a focus on improving our cost structure and business processes through various means including consolidation of certain manufacturing and select back office operations, customer rationalizations and various other organizational changes.  The charges associated with these actions are summarized below.
	2013 Actions
		·	During the second quarter of fiscal 2013, we announced a plan to improve our cost structure and streamline our organization by eliminating in excess of 100 positions across the Company, roughly half of which are contract and open positions.  This resulted in a special charge of $1.7 million related to severance and other benefits to be provided to affected employees.  We also incurred a contract termination charge of $0.6 million, a non-cash asset impairment charge of $0.2 million related to a product discontinuance action and $1.0 million in other related costs.  During the third and fourth quarters of fiscal 2013, we continued actions under the previously announced plan and incurred charges of $0.8 million and $2.0 million, respectively. These actions were substantially complete by the end of fiscal year 2013, but certain cash expenditures will occur in fiscal 2014.
	2012 Actions
		·	During the fourth quarter of fiscal 2012, we recorded a non-cash impairment charge of $4.7 million for certain tangible assets for which the carrying values could not be fully recovered as a result of strategic decisions made relative to the exiting of underperforming portions of our home care business.  Also associated with this action was the elimination of approximately 100 positions and the related charge of $1.0 million, primarily related to severance and other benefits to be provided to the affected employees.  These actions and the related cash expenditures were substantially complete by the end of fiscal year 2013.
		·	During the second quarter of fiscal 2012, we announced a plan to improve our cost structure and streamline our organization by, among other things, eliminating approximately 200 positions across the Company resulting in a special charge of $9.3 million, net of reversals, recognized throughout fiscal 2012 primarily related to severance and other benefits to be provided to the affected employees, $0.6 million of which was determined to be excessive and was reversed in the second quarter of fiscal 2013.  We also recorded an impairment of certain tangible assets for which the carrying values could not be fully recovered as a result of various strategic decisions, which resulted in a non-cash charge of $3.2 million.  In addition, we recorded a non-cash impairment charge of $8.0 million related to a previously acquired trade name whose assessment was triggered by strategic changes in how the asset would be utilized on a go forward basis.  These actions and the related cash expenditures were complete by the end of fiscal year 2013.
	2011 Actions
		·	During the second quarter of fiscal 2011, we recorded an additional special charge of $2.6 million related to our fiscal 2010 fourth quarter action.  The majority of the charge related to additional severance and other benefits provided to affected employees of that action as well as a write-down of assets held for sale.  During the third quarter of fiscal 2011, we recorded a benefit of $1.2 million primarily related to the net reversal of severance recorded in relation to our fourth quarter of fiscal 2010 restructuring action, partially offset by an additional write-down of assets held for sale.  These actions and related cash expenditures were completed by the end of fiscal year 2013.
	Severance activity related to these actions during fiscal 2013 was as follows:
			Beginning										Ending
			Balance										Balance
			September 30,										September 30,
			2012		Expenses		Cash Payments			Reversals			2013
	Fiscal 2013 Action		$	-	$	4.5	$	(1.9	)	$	-		$	2.6
	Prior Restructuring Actions			4.7		-		(3.8	)		(0.6	)		0.3
	Total		$	4.7	$	4.5	$	(5.7	)	$	(0.6	)	$	2.9

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Sep. 30, 2013
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 9. INCOME TAXES
	The significant components of income before income taxes and the consolidated income tax provision were as follows:
			Years Ended September 30
			2013			2012			2011
	Income before income taxes:
	Domestic		$	120		$	148.6		$	122.5
	Foreign			24			14.9			37.2
	Total		$	144		$	163.5		$	159.7
	Income tax expense:
	Current provision
	Federal		$	45		$	65.9		$	41.1
	State			1.8			4.3			2.3
	Foreign			7			4.8			4.3
	Total current provision			53.8			75			47.7
	Deferred provision:
	Federal			(9.9	)		(29.2	)		(0.8	)
	State			1.1			0.1			(0.2	)
	Foreign			(6.0	)		(3.2	)		(20.5	)
	Total deferred provision			(14.8	)		(32.3	)		(21.5	)
	Income tax expense		$	39		$	42.7		$	26.2
	Differences between income tax expense reported for financial reporting purposes and that computed based upon the application of the statutory U.S. Federal tax rate to the reported income before income taxes were as follows:
			Years Ended September 30
			2013						2012						2011
						% of						% of						% of
						Pretax						Pretax						Pretax
			Amount			Income			Amount			Income			Amount			Income
	Federal income tax (a)		$	50.4			35		$	57.2			35		$	55.9			35
	State income tax (b)			2.5			1.7			3.5			2.2			2.4			1.5
	Foreign income tax (c)			(5.7	)		(4.0	)		(3.4	)		(2.1	)		(8.0	)		(5.0	)
	International tax restructuring			(0.8	)		(0.6	)		(11.0	)		(6.7	)		-			-
	Application of federal tax credits			(3.5	)		(2.4	)		(0.6	)		(0.4	)		(4.1	)		(2.5	)
	Adjustment of estimated income tax accruals			(1.5	)		(1.0	)		(2.1	)		(1.3	)		2.3			1.4
	Valuation of tax attributes			0.6			0.4			0.3			0.2			(19.5	)		(12.2	)
	Other, net			(3.0	)		(2.0	)		(1.2	)		(0.8	)		(2.8	)		(1.8	)
	Income tax expense		$	39			27.1		$	42.7			26.1		$	26.2			16.4
	(a)	At statutory rate.
	(b)	Net of Federal benefit.
	(c)	Federal tax rate differential.
	The tax effect of temporary differences that gave rise to the deferred tax balance sheet accounts were as follows:
			Years Ended September 30
			2013			2012
	Deferred tax assets:
	Employee benefit accruals		$	46.6		$	53.9
	Reserve for bad debts			10.1			12.4
	Accrued warranty			9.7			10.5
	Net operating loss carryforwards			38.3			39.4
	Tax credit carryforwards			2			1.8
	Other, net			23.7			26.7
				130.4			144.7
	Less:  Valuation allowance			(8.9	)		(8.6	)
	Total deferred tax assets			121.5			136.1
	Deferred tax liabilities:
	Depreciation			(32.1	)		(33.9	)
	Amortization			(67.5	)		(81.1	)
	Other, net			(3.2	)		(2.0	)
	Total deferred tax liabilities			(102.8	)		(117.0	)
	Deferred tax asset - net		$	18.7		$	19.1
	At September 30, 2013, we had $37.7 million of deferred tax assets related to operating loss carryforwards in foreign jurisdictions that are subject to various carryforward periods with the majority eligible to be carried forward for an unlimited period.  We also had $0.6 million of deferred tax assets related to state net operating loss carryforwards, which expire between 2018 and 2026.  For tax credits, we had $2.0 million of deferred tax assets related to state credits, which expire between 2014 and 2026.
	The gross deferred tax assets as of September 30, 2013 were reduced by valuation allowances of $8.9 million primarily related to certain foreign deferred tax attributes as it is more likely than not that some portion or all of these tax attributes will not be realized.  In evaluating whether it is more likely than not that we would recover our deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies were considered. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.
	We operate under tax holidays in both Singapore and Puerto Rico.  The Singapore tax holiday is effective through 2016 while the Puerto Rico tax holiday is effective through 2025.  Both incentives are conditional on meeting certain employment and/or investment thresholds.  The impact of these tax holidays decreased foreign taxes by $2.9 million in fiscal 2013, $1.7 million for fiscal 2012 and $0.7 million for fiscal 2011.  The benefit of the tax holidays on net income per share (diluted) was $0.05, $0.03 and $0.01 for fiscal 2013, 2012 and 2011, respectively.
	We file a consolidated federal income tax return as well as multiple state, local and foreign jurisdiction tax returns.  In the normal course of business, we are subject to examination by the taxing authorities in each of the jurisdictions where we file tax returns.  During fiscal 2013, the Internal Revenue Service ("IRS") concluded its audit for fiscal year 2011 and initiated its post-filing examination of the fiscal 2012 consolidated federal return.  We continue to participate in the IRS Compliance Assurance Program ("CAP") for fiscal year 2013 and have submitted the application to remain in the CAP for fiscal years 2014 and 2015.  The CAP provides the opportunity for the IRS to review certain tax matters prior to us filing our tax return for the year, thereby reducing the time it takes to complete the post-filing examination. We are also subject to state and local or foreign income tax examinations by taxing authorities for years back to fiscal 2007.
	We also have on-going audits in various stages of completion in several state and foreign jurisdictions, one or more of which may conclude within the next 12 months. Such settlements could involve some or all of the following: the payment of additional taxes, the adjustment of certain deferred taxes and/or the recognition of unrecognized tax benefits.  The resolution of these matters, in combination with the expiration of certain statutes of limitations in various jurisdictions, make it reasonably possible that our unrecognized tax benefits may decrease as a result of either payment or recognition by approximately $2 to $3 million in the next twelve months, excluding interest.
	The total amount of gross unrecognized tax benefits as of September 30, 2013, 2012 and 2011 was $4.6 million, $9.8 million and $17.8 million, which includes $3.9 million, $8.4 million and $11.5 million that, if recognized, would impact the effective tax rate in future periods. The remaining amount relates to items which, if recognized, would not impact our effective tax rate.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
		Years Ended September 30
		2013			2012			2011
Balance at October 1		$	9.8		$	17.8		$	24
Increases in tax position of prior years			-			0.5			0.4
Decreases in tax position of prior years			(0.5	)		(2.7	)		(3.0	)
Increases in tax positions related to the current year			0.1			-			5.1
Settlements with taxing authorities			(3.2	)		(3.8	)		(5.2	)
Lapse of applicable statute of limitations			(1.7	)		(1.9	)		(3.5	)
Foreign currency adjustments			0.1			(0.1	)		-
Total change			(5.2	)		(8.0	)		(6.2	)
Balance at September 30		$	4.6		$	9.8		$	17.8
We recognize accrued interest and penalties related to unrecognized tax benefits as a component of income tax expense.  Accrued interest and penalties, which are not presented in the reconciliation table above, were $0.6 million, $0.8 million and $1.9 million at September 30, 2013, 2012 and 2011.  Related to interest and penalties, we recognized an income tax benefit (expense) of $0.1 million in 2013, less than $0.1 million in 2012 and ($0.1) million in 2011.

EARNINGS_PER_COMMON_SHARE

EARNINGS PER COMMON SHARE	12 Months Ended
	Sep. 30, 2013
EARNINGS PER COMMON SHARE [Abstract]	'
EARNINGS PER COMMON SHARE	'
	NOTE 10. EARNINGS PER COMMON SHARE
	Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares. Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs. For all years presented, anti-dilutive stock options were excluded from the calculation of dilutive earnings per share. Excluded shares were 1.4 million, 1.4 million and 0.6 million for fiscal years 2013, 2012 and 2011. Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.
	Earnings per share is calculated as follows:
		Years Ended September 30
		2013		2012		2011
	Net income attributable to common shareholders	$	105	$	120.8	$	133.3
	Average shares outstanding - Basic (thousands)		59,910		62,120		63,164
	Add potential effect of exercise of stock options
	and other unvested equity awards (thousands)		340		241		735
	Average shares outstanding - Diluted (thousands)		60,250		62,361		63,899
	Net income attributable to common shareholders
	per common share - Basic	$	1.75	$	1.94	$	2.11
	Net income attributable to common shareholders
	per common share - Diluted	$	1.74	$	1.94	$	2.09

SEGMENT_REPORTING

SEGMENT REPORTING	12 Months Ended
	Sep. 30, 2013
SEGMENT REPORTING [Abstract]	'
SEGMENT REPORTING	'
	NOTE 11. SEGMENT REPORTING
	We disclose segment information that is consistent with the way in which management operates and views the business.  During the fourth quarter of fiscal 2013, we changed our definition of divisional income within our segment reporting as outlined below.  All segment information included below has been updated to reflect these changes.
	Our operating structure consists of the following three reporting segments:
		·	North America - sells and rents our patient support and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.
		·	Surgical and Respiratory Care - sells and rents our surgical and respiratory care products.
		·	International - sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
	Our performance under each reportable segment is measured on a divisional income basis before corporate expenses and other non-allocated operating costs, impairment of goodwill and other intangibles, litigation and special charges.  Divisional income generally represents the division's gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and certain corporate functional expenses.
	Corporate expenses and other non-allocated operating costs, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. Corporate expenses include functional expenses that support the entire organization such as administration, finance, legal and human resources.  Other non-allocated operating costs generally include expenses associated with strategic developments and other unusual events that are not indicative of operating trends.  We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends without the effects of such items.
			Years Ended September 30
			2013			2012			2011
	Revenue:
	North America		$	958.3		$	998.2		$	1,057.20
	Surgical and Respiratory Care			245.8			153.2			132.9
	International			512.1			482.9			401.6
	Total revenue		$	1,716.20		$	1,634.30		$	1,591.70
	Divisional income:
	North America		$	194.6		$	208.4		$	228.3
	Surgical and Respiratory Care			46.1			41.7			40
	International			23.1			24.2			27.9
	Other operating costs:
	Corporate expenses and other non-allocated operating costs			103.2			82.9			80.7
	Impairment of goodwill and other intangibles			-			8			-
	Litigation (credit) charge			-			(3.6	)		47.3
	Special charges			5.7			18.2			1.4
	Operating profit			154.9			168.8			166.8
	Interest expense			(9.5	)		(6.5	)		(8.5	)
	Investment income and other, net			(1.4	)		1.2			1.4
	Income before income taxes		$	144		$	163.5		$	159.7
	Geographic Information
	Geographic data for net revenue and long-lived assets (which consist mainly of property and equipment leased to others) were as follows:
			Years Ended September 30
			2013			2012			2011
	Net revenue to unaffiliated customers: (a)
	United States		$	1,116.40		$	1,077.80		$	1,105.00
	Foreign			599.8			556.5			486.7
	Total revenue		$	1,716.20		$	1,634.30		$	1,591.70
	Long-lived assets: (b)
	United States		$	158		$	172.5		$	180.2
	Foreign			76.3			77.6			42.6
	Total long-lived assets		$	234.3		$	250.1		$	222.8
	(a)	Net revenue is attributed to geographic areas based on the location of the customer.
	(b)	Includes property and equipment leased to others.

QUARTERLY_FINANCIAL_INFORMATIO

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	12 Months Ended
	Sep. 30, 2013
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) [Abstract]	'
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	'
	NOTE 12. QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
	The following table presents selected consolidated financial data by quarter for each of the last two fiscal years.
	2013 Quarter Ended	December 31,		March 31,		June 30,		September 30,
		2012		2013		2013		2013
	Net revenue	$	428.4	$	425.7	$	424.2	$	437.9
	Gross profit	$	191.4	$	196.1	$	190.1	$	202.7
	Net income attributable to common shareholders	$	24	$	22.3	$	23.4	$	35.3
	Basic net income attributable to common
	shareholders per common share	$	0.39	$	0.37	$	0.39	$	0.6
	Diluted net income attributable to common
	shareholders per common share	$	0.39	$	0.37	$	0.39	$	0.59
	2012 Quarter Ended	December 31,		March 31,		June 30,		September 30,
		2011		2012		2012		2012
	Net revenue	$	381.1	$	415.1	$	406.5	$	431.6
	Gross profit	$	185.1	$	195.8	$	172.7	$	201.1
	Net income attributable to common shareholders	$	32.9	$	25.3	$	23.4	$	39.2
	Basic net income attributable to common
	shareholders per common share	$	0.53	$	0.41	$	0.38	$	0.63
	Diluted net income attributable to common
	shareholders per common share	$	0.53	$	0.4	$	0.37	$	0.63

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Sep. 30, 2013
COMMITMENTS AND CONTINGENCIES [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 13. COMMITMENTS AND CONTINGENCIES
	Lease Commitments
	Rental expense for fiscal years 2013, 2012 and 2011 was $21.5 million, $20.7 million and $20.0 million. The table below indicates the minimum annual rental commitments (excluding renewable periods) aggregating $61.6 million, for manufacturing facilities, warehouse distribution centers, service centers and sales offices, under non-cancelable operating leases.
		Amount
	2014	$	20.9
	2015	$	13.9
	2016	$	10.6
	2017	$	8.2
	2018	$	4.1
	2019 and beyond	$	3.9
	During fiscal 2013, we terminated a long-term agreement with IBM to manage our global information structure environment that expired in September 2014 and paid a termination fee of $0.6 million, which was accrued as of September 30, 2012.
	Self Insurance
	We are also involved in other possible claims, including product and general liability, workers' compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions ranging from $25 thousand to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower.  We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Consolidated Balance Sheets.
	Legal Proceedings
	Stryker Litigation
	On April 4, 2011, we filed two separate actions against Stryker Corporation alleging infringement of certain Hill-Rom patents covering proprietary communications networks, status information systems and powered wheels used in our beds or stretchers.  Both suits seek monetary damages and injunctions against Stryker for selling or distributing any beds, stretchers or ancillary products that infringe Hill-Rom's patents. Stryker responded with counterclaims seeking declaratory judgment for noninfringement and invalidity for several of the patents at issue, and has filed counterclaims alleging infringement of three of their patents.  On August 14, 2012, we entered into a confidential favorable settlement agreement with Stryker Corporation fully resolving all of their counterclaims and our lawsuit regarding claims about our powered wheel patents.  The remaining lawsuit does not contain counterclaims alleging infringement of Stryker's patents.  No trial date for the remaining lawsuit has been set.  Because the litigation is in a preliminary stage, we cannot assess the likelihood of a positive or negative outcome or determine an estimate, or a range of estimates, of potential damages, nor can we give any assurances that this matter will not have a material adverse impact on our financial condition, results of operations or cash flows.
	Office of Inspector General Investigation
	In June 2011, we reached agreement with respect to a tentative financial settlement related to a qui tam complaint under the False Claims Act and recognized a charge in the third quarter of $42.3 million.  This settlement was finalized and paid in September 2011.  Concurrently with this settlement, we entered into a five year Corporate Integrity Agreement, which provides for certain other compliance-related activities during the five year term of the agreement, including specific written standards, monitoring, training, education, independent review, disclosure and reporting requirements. We did not admit any wrongdoing as part of the settlement.
	Freedom Medical Antitrust Litigation
	In September 2011, we settled an action brought by Freedom Medical, Inc. against us, another manufacturer and two group purchasing organizations alleging violations of antitrust laws in exchange for a payment of $5.0 million.  We did not admit any wrongdoing as part of the settlement.
	General
	We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental  and other matters.  Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.  It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Sep. 30, 2013
Valuation and Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	Valuation and Qualifying Accounts
	For The Fiscal Years Ended September 30, 2013, 2012 and 2011
	(Dollars in millions)
					ADDITIONS
			BALANCE AT		CHARGED TO			CHARGED TO				DEDUCTIONS				BALANCE
			BEGINNING		COSTS AND			OTHER				NET OF				AT END
	DESCRIPTION		OF PERIOD		EXPENSES			ACCOUNTS				RECOVERIES				OF PERIOD
	Reserves deducted from assets to which they apply:
	Allowance for possible losses and sales returns -
	accounts receivable:
	Period Ended:
	30-Sep-13		$	38.5	$	2.7		$	(0.1	)	(a)	$	(11.0	)	(b)	$	30.1
	30-Sep-12		$	26.7	$	1.6		$	18.5		(a)	$	(8.3	)	(b)	$	38.5
	30-Sep-11		$	29	$	1.5		$	3.1		(a)	$	(6.9	)	(b)	$	26.7
	Allowance for inventory valuation:
	Period Ended:
	30-Sep-13		$	22	$	1.8		$	-		(c)	$	(1.8	)	(d)	$	22
	30-Sep-12		$	22.9	$	2.2		$	1.6		(c)	$	(4.7	)	(d)	$	22
	30-Sep-11		$	24.7	$	3.7		$	-		(c)	$	(5.5	)	(d)	$	22.9
	Valuation allowance against deferred tax assets:
	Period Ended:
	30-Sep-13		$	8.6	$	0.6		$	-			$	(0.3	)	(e)	$	8.9
	30-Sep-12		$	8.1	$	0.4		$	-			$	0.1		(e)	$	8.6
	30-Sep-11		$	28.5	$	(19.5	)	$	-			$	(0.9	)	(e)	$	8.1
	(a)	Reduction of gross revenue for uncollectible health care rental reimbursements, cash discounts and other adjustments in determining net revenue.  Also includes the effect of acquired businesses, if any.
	(b)	Generally reflects the write-off  of specific receivables against recorded reserves.
	(c)	Generally reflects the effect of acquired businesses, if any.
	(d)	Generally reflects the write-off of specific inventory against recorded reserves.
	(e)	Primarily reflects write-offs of deferred tax assets against the valuation allowance and other movement of the valuation allowance offset by an opposing change in deferred tax assets.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Nature of Operations	'
	Nature of Operations
	Hill-Rom Holdings, Inc. (the "Company," "Hill-Rom," "we," "us," or "our") was incorporated on August 7, 1969 in the State of Indiana and is headquartered in Batesville, Indiana. We are a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Our comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings, to enhance the safety and quality of patient care.
Basis of Presentation and Principles of Consolidation	'
	Basis of Presentation and Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Hill-Rom and its subsidiaries.  All subsidiaries are wholly-owned as of September 30, 2013.  During the first quarter of our fiscal 2011, we acquired the remaining 40 percent noncontrolling interest in a former joint venture (Note 2).  Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Examples of such estimates include our accounts receivable reserves (Note 1), accrued warranties (Note 1), the impairment of intangibles and goodwill (Note 3), investments (Note 5), income taxes (Note 9) and commitments and contingencies (Note 13), among others.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	We consider investments in marketable securities and other highly liquid instruments with a maturity of three months or less at date of purchase to be cash equivalents. Investments which have no stated maturity are also considered cash equivalents. All of our marketable securities may be freely traded.
Investment Securities	'
	Investment Securities
	At September 30, 2013, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").  These securities are generally insured through the U.S. government's Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.  These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Income (Loss) ("AOCL").
	We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria. The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery. If there is a decline in a security's net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.  The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.
	See Note 5 for further details on our fair value measurements.
Trade Accounts Receivable	'
	Trade Accounts Receivable
	Trade accounts receivable are recorded at the invoiced amount and do not bear interest, unless the transaction is an installment sale with payment terms exceeding one year. Reserves for uncollectible accounts represent our best estimate of the amount of probable credit losses and collection risk in our existing accounts receivable. We determine such reserves based on historical write-off experience by industry and reimbursement platform. Receivables are generally reviewed on a pooled basis based on historical collection experience for each reimbursement and receivable type. Receivables for capital sales transactions are also reviewed individually for collectability. Account balances are charged against the allowance when we believe it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers. If circumstances change, such as higher than expected claims denials, payment defaults, changes in our business composition or processes, adverse changes in general economic conditions, unfavorable impacts of austerity measures initiated by some governmental authorities, instability or disruption of credit markets, or an unexpected material adverse change in a major customer's or payor's ability to meet its obligations, our estimates of the realizability of trade receivables could be reduced by a material amount.
	Within rental revenue, the domestic third-party payors' reimbursement process requires extensive documentation, which has had the effect of slowing both the billing and cash collection cycles relative to the rest of the business, and therefore, increasing total accounts receivable. Because of the extensive documentation required and the requirement to settle a claim with the primary payor prior to billing the secondary and/or patient portion of the claim, the collection period for a claim in a portion of our business may, in some cases, be extended.
	We generally hold our trade accounts receivable until they are paid. Certain long-term receivables are occasionally sold to third parties; however, any recognized gain or loss on such sales has historically not been material.
Inventories	'
	Inventories
	Inventories are valued at the lower of cost or market. Inventory costs are determined by the last-in, first-out ("LIFO") method for approximately 47 and 44 percent of our inventories at September 30, 2013 and 2012. Costs for other inventories have been determined principally by the first-in, first-out ("FIFO") method. Inventories consist of the following:
			30-Sep
			2013			2012
	Finished products		$	66.3		$	71.8
	Work in process			5.8			6.4
	Raw materials			46.2			48.7
	Total		$	118.3		$	126.9
	If the FIFO method of inventory accounting, which approximates current cost, had been used for all inventories, they would have been approximately $3.2 million and $3.1 million higher than reported at September 30, 2013 and 2012.
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Property, plant and equipment is recorded at cost and depreciated over the estimated useful life of the assets using principally the straight-line method. Ranges of estimated useful lives are as follows:
			Useful Life
	Land improvements		6 - 15 years
	Buildings and building equipment		10 - 40 years
	Machinery and equipment		3 - 10 years
	Equipment leased to others		2 -10 years
	When property, plant and equipment is retired from service or otherwise disposed of, the cost and related amount of depreciation or amortization are eliminated from the asset and accumulated depreciation accounts. The difference, if any, between the net asset value and the proceeds on sale are charged or credited to income. Total depreciation expense for fiscal years 2013, 2012 and 2011 was $71.2 million, $73.9 million and $74.3 million. The major components of property and the related accumulated depreciation were as follows:
			30-Sep
			2013						2012
						Accumulated						Accumulated
			Cost			Depreciation			Cost			Depreciation
	Land and land improvements		$	14		$	2.1		$	16.1		$	4.4
	Buildings and building equipment			143.1			84.6			142.6			85.8
	Machinery and equipment			288			198.8			276.3			187.6
	Equipment leased to others			376.6			301.9			399.9			307
	Total		$	821.7		$	587.4		$	834.9		$	584.8
Intangible Assets	'
	Intangible Assets
	Intangible assets are stated at cost and consist predominantly of goodwill, software, patents, trademarks, and acquired customer relationship assets. With the exception of goodwill and certain trademarks, our intangible assets are amortized on a straight-line basis over periods generally ranging from 3 to 20 years.
	We assess the carrying value of goodwill and non-amortizable intangibles annually, during the third quarter of each fiscal year, or more often if events or changes in circumstances indicate there may be impairment. Goodwill is allocated among the reporting units based on the relative fair value of those units.
	The majority of our goodwill and many of our intangible assets are not deductible for income tax purposes. A summary of intangible assets and the related accumulated amortization and impairment losses follows:
			30-Sep
			2013						2012
						Amortization						Amortization
			Cost			and Impairment			Cost			and Impairment
	Goodwill		$	815.6		$	472.8		$	808		$	472.8
	Software			164.6			135.9			163.2			123.7
	Other			336.4			112.4			334.4			83.1
	Total		$	1,316.60		$	721.1		$	1,305.60		$	679.6
	Amortization expense for fiscal years 2013, 2012 and 2011 was $45.6 million, $37.8 million and $29.6 million. Amortization expense for all intangibles is expected to approximate the following for each of the next five fiscal years and thereafter:
			Amount
	2014		$	39.8
	2015		$	36.4
	2016		$	29.2
	2017		$	20.6
	2018		$	17
	2019 and beyond		$	76.8
	Software consists mainly of capitalized costs associated with internal use software, including applicable costs associated with the implementation/upgrade of our Enterprise Resource Planning system. In addition, software includes capitalized development costs for software products to be sold. The net book value of computer software costs, included within intangible assets, was $28.7 million and $39.5 million at September 30, 2013 and 2012. Capitalized software costs are amortized on a straight-line basis over periods ranging from three to ten years. Software amortization expense approximated $17.8 million, $20.7 million and $19.1 million for fiscal years 2013, 2012 and 2011, and is included in the total intangibles amortization presented earlier.
Guarantees	'
	Guarantees
	We routinely grant limited warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods. We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve. The amount of the warranty reserve is determined based on historical trend experience for the covered products. For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  During fiscal 2013, we have recognized charges of $12.2 million to cover the estimated costs associated with field corrective actions on five different product lines.  We also recognized a charge of $16.0 million for a fiscal 2012 field corrective action on one of our med-surg product lines.  These field corrective actions do not limit the manufacture, sale or ongoing use of these products.
	A reconciliation of changes in our warranty reserve is as follows:
			2013			2012			2011
	Balance at October 1		$	42.2		$	17.8		$	15.8
	Provision for warranties during the period			29.2			31.8			17
	Warranty reserves acquired			(2.6	)		9.7			-
	Warranty claims incurred during the period			(30.7	)		(17.1	)		(15.0	)
	Balance at September 30		$	38.1		$	42.2		$	17.8
	In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others. Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners. These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.
	In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of our commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.
Retirement Plans	'
	Retirement Plans
	We sponsor retirement and postretirement plans covering select employees. Expense recognized in relation to these defined benefit retirement plans and the postretirement health care plan in the U.S. is based upon actuarial valuations and inherent in those valuations are key assumptions including discount rates, and where applicable, expected returns on assets, projected future salary rates and projected health care cost trends. The discount rates used in the valuation of our defined benefit pension and postretirement plans are evaluated annually based on current market conditions. In setting these rates we utilize long-term bond indices and yield curves as a preliminary indication of interest rate movements, and then make adjustments to the respective indices to reflect differences in the terms of the bonds covered under the indices in comparison to the projected outflow of our obligations. Our overall expected long-term rate of return on pension assets is based on historical and expected future returns, which are inflation adjusted and weighted for the expected return for each component of the investment portfolio. Our rate of assumed compensation increase is also based on our specific historical trends of wage adjustments.
	We account for our defined benefit pension and other postretirement plans by recognizing the funded status of a benefit plan in the statement of financial position. We also recognize in Accumulated Other Comprehensive Income (Loss) certain gains and losses that arose during the period. See Note 6 for key assumptions and further discussion related to our pension and postretirement plans.
Environmental Liabilities	'
	Environmental Liabilities
	Expenditures that relate to an existing condition caused by past operations, and which do not contribute to future revenue generation, are expensed. A reserve is established when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These reserves are determined without consideration of possible loss recoveries from third parties.
	Specific costs included in environmental expense and reserves include site assessment, development of a remediation plan, clean-up costs, post-remediation expenditures, monitoring, fines, penalties and legal fees. Reserve amounts represent the expected undiscounted future cash outflows associated with such plans and actions.
Self Insurance	'
	Self Insurance
	We are also involved in other possible claims, including product and general liability, workers' compensation, auto liability and employment related matters. Such claims in the United States have deductibles and self-insured retentions ranging from $25 thousand to $1.0 million per occurrence or per claim, depending upon the type of coverage and policy period. International deductibles and self-insured retentions are lower.  We are also generally self-insured up to certain stop-loss limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Consolidated Balance Sheets.
Revenue Recognition - Sales and Rentals	'
	Revenue Recognition - Sales and Rentals
	Net revenue reflects gross revenue less sales discounts and allowances and customer returns for product sales and rental revenue reserves. Revenue is evaluated under the following criteria and recognized when each is met:
		•	Evidence of an arrangement: An agreement with the customer reflecting the terms and conditions to deliver products or services serves as evidence of an arrangement.
		•	Delivery: For products, delivery is considered to occur upon receipt by the customer and the transfer of title and risk of loss. For rental services, delivery is considered to occur when the services are rendered.
		•	Fixed or determinable price: The sales price is considered fixed or determinable if it is not subject to refund or adjustment.
		•	Collection is deemed probable: At or prior to the time of a transaction, credit reviews of each customer are performed to determine the creditworthiness of the customer. Collection is deemed probable if the customer is expected to be able to pay amounts under the arrangement as those amounts become due. If collection is not probable, revenue is recognized when collection becomes probable, generally upon cash collection.
	As a general interpretation of the above guidelines, revenue for health care and surgical products are generally recognized upon delivery of the products to the customer and their assumption of risk of loss and other risks and rewards of ownership. Local business customs and non-standard sales terms can sometimes result in deviations to this normal practice in certain instances; however, in no case is revenue recognized prior to the transfer of risk of loss and rewards of ownership.
	For non-invasive therapy products and medical equipment management services, the majority of product offerings are rental products for which revenue is recognized consistent with the rendering of the service and use of products. For The Vest® product, revenue is generally recognized at the time of receipt of authorization for billing from the applicable paying entity as this serves as evidence of the arrangement and sets a fixed or determinable price.
	For health care products and services aimed at improving operational efficiency and asset utilization, various revenue recognition techniques are used, depending on the offering. Arrangements to provide services, routinely under separately sold service and maintenance contracts, result in the deferral of revenue until specified services are performed. Service contract revenue is generally recognized ratably over the contract period, if applicable, or as services are rendered. Product-related goods are generally recognized upon delivery to the customer.
	Revenue is presented in the Statements of Consolidated Income net of certain discounts and sales adjustments. For product sales, we record reserves resulting in a reduction of revenue for contractual discounts, as well as price concessions and product returns. Likewise, rental revenue reserves, reflecting contractual and other routine billing adjustments, are recorded as a reduction of revenue. Reserves for revenue are estimated based upon historical rates for revenue adjustments.
Taxes Collected from Customers and Remitted to Governmental Units	'
	Taxes Collected from Customers and Remitted to Governmental Units
	Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes, and value added taxes, are accounted for on a net (excluded from revenue and cost) basis.
Cost of Revenue	'
	Cost of Revenue
	Cost of goods sold for capital sales consists primarily of purchased material costs, fixed manufacturing expense, variable direct labor, overhead costs and costs associated with the distribution and delivery of products to our customers. Rental expenses consist of costs associated directly with rental revenue, including depreciation, maintenance, logistics and service center facility and personnel costs.
Research and Development Costs	'
	Research and Development Costs
	Research and development costs are expensed as incurred. Costs were $70.2 million, $66.9 million and $63.8 million for fiscal years 2013, 2012 and 2011.
	In addition, certain software development technology costs are capitalized as intangibles and are amortized over a period of three to five years once the software is ready for its intended use. The amount capitalized during fiscal years 2013, 2012 and 2011 was approximately $2.4 million, $2.3 million and $2.1 million.
Advertising Costs	'
	Advertising Costs
	Advertising costs are expensed as incurred. Costs were $7.4 million, $4.4 million and $4.0 million for fiscal years 2013, 2012 and 2011.
Comprehensive Income	'
	Comprehensive Income
	We include the net-of-tax effect of unrealized gains or losses on our available-for-sale securities, foreign currency translation adjustments and pension or other defined benefit postretirement plans' actuarial gains or losses and prior service costs or credits in comprehensive income.
	The composition of accumulated other comprehensive (loss) income, net of applicable taxes, is as follows:
			30-Sep
			2013			2012			2011
	Available-for-sale securities and hedges		$	(0.3	)	$	(0.4	)	$	(0.9	)
	Foreign currency translation adjustment			(4.6	)		(17.2	)		(15.7	)
	Items not yet recognized as a component of net periodic pension
	and postretirement healthcare costs			(30.8	)		(60.4	)		(62.4	)
	Total		$	(35.7	)	$	(78.0	)	$	(79.0	)
Foreign Currency Translation	'
	Foreign Currency Translation
	The functional currency of foreign operations is generally the local currency in the country of domicile. Assets and liabilities of foreign operations are primarily translated into U.S. dollars at year-end rates of exchange and the income statements are translated at the average rates of exchange prevailing during the year. Adjustments resulting from translation of the financial statements of foreign operations into U.S. dollars are excluded from the determination of net income, but included as a component of Accumulated Other Comprehensive Income (Loss). Foreign currency gains and losses resulting from foreign currency transactions are included in our results of operations and are not material.
Stock-Based Compensation	'
	Stock-Based Compensation
	We account for stock-based compensation under fair value provisions. Stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the vesting period. In order to determine the fair value of stock options and other performance-based stock awards on the date of grant, we utilize a Binomial model. Inherent in this model are assumptions related to a volatility factor, expected life, risk-free interest rate, dividend yield and expected forfeitures. The risk-free interest rate is based on factual data derived from public sources. The volatility factor, expected life, dividend yield and expected forfeiture assumptions require judgment utilizing historical information, peer data and future expectations. Deferred stock (also known as restricted stock units ("RSUs")) is measured based on the fair market price of our common stock on the date of grant, as reported by the New York Stock Exchange, multiplied by the number of units granted.  See Note 7 for further details.
Income Taxes	'
	Income Taxes
	The Company and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions. Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability and if it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.
	We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit. See Note 9 for further details.
Derivative Instruments and Hedging Activity	'
	Derivative Instruments and Hedging Activity
	We use derivative financial instruments to manage the economic impact of fluctuations in currency exchange and interest rates. Derivative financial instruments related to currency exchange rates include forward purchase and sale agreements which generally have terms no greater than 15 months. Additionally, interest rate swaps are used to convert some or all of our long term debt to either a fixed or variable rate.
	Derivative financial instruments are recognized on the Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair value of derivatives are recorded each period in the Statement of Consolidated Income or Accumulated Other Comprehensive Income (Loss), depending on whether a derivative is designated and considered effective as part of a hedge transaction, and if it is, the type of hedge transaction.  Gains and losses on derivative instruments reported in Accumulated Other Comprehensive Income (Loss) are subsequently included in the Statement of Consolidated Income in the periods in which earnings are affected by the hedged item. These activities have not had a material effect on our financial position or results of operations for the periods presented herein.
Recently Issued Accounting Guidance	'
	Recently Issued Accounting Guidance
	In December 2011, the FASB issued a standard increasing disclosure about offsetting assets and liabilities.  For financial instruments and derivative instruments, the standard requires disclosure of the gross amounts of recognized assets and liabilities, the amounts offset on the balance sheet, and the amounts subject to the offsetting requirements but not offset on the balance sheet. In January 2013, the FASB issued updated guidance which clarified that the 2011 amendment to the balance sheet offsetting standard does not cover transactions that are not considered part of the guidance for derivatives and hedge accounting. The standard is effective for fiscal 2014 and is to be applied retrospectively. The adoption of this standard is not expected to have a significant impact on our Consolidated Financial Statements.
	In July 2012, the FASB issued an amendment to the authoritative guidance on the annual impairment test on indefinite-lived intangible assets.  The amendment provides the option to first assess qualitative factors to determine whether it is necessary to perform the current quantitative test.  If, as a result of the qualitative assessment, it is determined it is more likely than not that the fair value of an intangible asset is less than its carrying amount, the quantitative impairment test is required.  Otherwise, no further testing is required.  The amendment will be effective beginning October 1, 2013, however early adoption is permitted.  We will consider applying this guidance in connection with future annual intangible impairment tests.  We do not expect this to have a material impact on our Consolidated Financial Statements
	In February 2013, an accounting standards update was issued that amends the reporting of amounts reclassified out of accumulated other comprehensive income. This standard does not change the current requirements for reporting net income or other comprehensive income in the financial statements. However, the guidance requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component, either on the face of the financial statement where net income is presented or in the notes to the financial statements. The standard is effective for fiscal 2014 and is to be applied prospectively. The adoption of this standard is not expected to have a significant impact on our Consolidated Financial Statements.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Sep. 30, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]	'
Schedule of Inventories	'
	Inventories are valued at the lower of cost or market. Inventory costs are determined by the last-in, first-out ("LIFO") method for approximately 47 and 44 percent of our inventories at September 30, 2013 and 2012. Costs for other inventories have been determined principally by the first-in, first-out ("FIFO") method. Inventories consist of the following:
		30-Sep
		2013			2012
	Finished products	$	66.3		$	71.8
	Work in process		5.8			6.4
	Raw materials		46.2			48.7
	Total	$	118.3		$	126.9
Schedule of Ranges of Estimated Useful Lives	'
	Property, plant and equipment is recorded at cost and depreciated over the estimated useful life of the assets using principally the straight-line method. Ranges of estimated useful lives are as follows:
		Useful Life
	Land improvements	6 - 15 years
	Buildings and building equipment	10 - 40 years
	Machinery and equipment	3 - 10 years
	Equipment leased to others	2 -10 years
Schedule of Major Components of Property and Related Accumulated Depreciation	'
	The major components of property and the related accumulated depreciation were as follows:
		30-Sep
		2013						2012
					Accumulated						Accumulated
		Cost			Depreciation			Cost			Depreciation
	Land and land improvements	$	14		$	2.1		$	16.1		$	4.4
	Buildings and building equipment		143.1			84.6			142.6			85.8
	Machinery and equipment		288			198.8			276.3			187.6
	Equipment leased to others		376.6			301.9			399.9			307
	Total	$	821.7		$	587.4		$	834.9		$	584.8
Schedule of Intangible Assets and Related Accumulated Amortization and Impairment Losses	'
	The majority of our goodwill and many of our intangible assets are not deductible for income tax purposes. A summary of intangible assets and the related accumulated amortization and impairment losses follows:
		30-Sep
		2013						2012
					Amortization						Amortization
		Cost			and Impairment			Cost			and Impairment
	Goodwill	$	815.6		$	472.8		$	808		$	472.8
	Software		164.6			135.9			163.2			123.7
	Other		336.4			112.4			334.4			83.1
	Total	$	1,316.60		$	721.1		$	1,305.60		$	679.6
Schedule of Expected Amortization Expense	'
	Amortization expense for fiscal years 2013, 2012 and 2011 was $45.6 million, $37.8 million and $29.6 million. Amortization expense for all intangibles is expected to approximate the following for each of the next five fiscal years and thereafter:
		Amount
	2014	$	39.8
	2015	$	36.4
	2016	$	29.2
	2017	$	20.6
	2018	$	17
	2019 and beyond	$	76.8
Reconciliation of Changes in Warranty Reserve	'
	A reconciliation of changes in our warranty reserve is as follows:
		2013			2012			2011
	Balance at October 1	$	42.2		$	17.8		$	15.8
	Provision for warranties during the period		29.2			31.8			17
	Warranty reserves acquired		(2.6	)		9.7			-
	Warranty claims incurred during the period		(30.7	)		(17.1	)		(15.0	)
	Balance at September 30	$	38.1		$	42.2		$	17.8
Schedule of Composition of Accumulated Other Comprehensive Income (Loss)	'
	The composition of accumulated other comprehensive (loss) income, net of applicable taxes, is as follows:
		30-Sep
		2013			2012			2011
	Available-for-sale securities and hedges	$	(0.3	)	$	(0.4	)	$	(0.9	)
	Foreign currency translation adjustment		(4.6	)		(17.2	)		(15.7	)
	Items not yet recognized as a component of net periodic pension
	and postretirement healthcare costs		(30.8	)		(60.4	)		(62.4	)
	Total	$	(35.7	)	$	(78.0	)	$	(79.0	)

ACQUISITIONS_Tables

ACQUISITIONS (Tables)	12 Months Ended
	Sep. 30, 2013
Aspen [Member]	'
Business Acquisition [Line Items]	'
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed	'
	Throughout fiscal 2013, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.  The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.
		Amount
	Inventory	$	25.6
	Other current assets		19.7
	Property, plant, and equipment		24.6
	Goodwill		220.1
	Trade name (Indefinite Lived)		29
	Trade name (15-year weighted-average useful life)		4.6
	Customer relationships (13-year weighted-average useful life)		121.9
	Technology (10-year weighted-average useful life)		9.1
	Other noncurrent assets		1.6
	Current liabilities		(14.0	)
	Deferred tax liability		(41.0	)
	Total purchase price	$	401.2
Volker [Member]	'
Business Acquisition [Line Items]	'
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed	'
	The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.
		Amount
	Goodwill	$	32.9
	Trade name (7-year useful life)		12.3
	Customer relationships (8-year weighted average useful life)		17.5
	Net assets acquired		24.6
	Deferred tax liability		(10.6	)
	Total purchase price	$	76.7
Encompass TSS, LLC [Member]	'
Business Acquisition [Line Items]	'
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed	'
	The following table summarizes the fair value of the assets acquired and liabilities assumed at the date of formation.
		Amount
	Goodwill	$	8
	Trade Name (7-year useful life)		1.5
	Customer relationships  (7-year useful life)		7.7
	Technology (5-year useful life)		2.4
	Net liabilities assumed		(0.7	)
	Noncontrolling interest		(7.5	)
	Additional paid-in-capital		(3.9	)
	Total purchase price	$	7.5

IMPAIRMENT_OF_GOODWILL_AND_OTH1

IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES (Tables)	12 Months Ended
	Sep. 30, 2013
IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES [Abstract]	'
Schedule of Goodwill Activity	'
	The following summarizes goodwill activity by reportable segment:
		North America			Surgical and		International			Total
					Respiratory Care
	Balances at September 30, 2011:
	Goodwill		383			56.2		120.8			560
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2011		24.9			56.2		6.1			87.2
	Changes in Goodwill during the period:
	Goodwill related to acquisition		-			215.3		35.1			250.4
	Currency translation effect		-			-		(2.4	)		(2.4	)
	Balances at September 30, 2012:
	Goodwill		383			271.5		153.5			808
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2012		24.9			271.5		38.8			335.2
	Changes in Goodwill during the period:
	Goodwill related to acquisition		-			4.8		(1.9	)		2.9
	Currency translation effect		-			2.7		2			4.7
	Balances at September 30, 2013:
	Goodwill		383			279		153.6			815.6
	Accumulated impairment losses		(358.1	)		-		(114.7	)		(472.8	)
	Goodwill, net at September 30, 2013	$	24.9		$	279	$	38.9		$	342.8

FINANCING_AGREEMENTS_Tables

FINANCING AGREEMENTS (Tables)	12 Months Ended
	Sep. 30, 2013
FINANCING AGREEMENTS [Abstract]	'
Schedule of Total Debt	'
	Total debt consists of the following:
		Years Ended September 30
		2013		2012
	Outstanding finance credit lines	$	-	$	0.2
	Revolving credit facility		70		105
	Term loan current portion		11.2		10
	Term loan long-term portion		176.2		187.5
	Unsecured 7.00% debentures due on February 15, 2024		19.6		19.6
	Unsecured 6.75% debentures due on December 15, 2027		29.8		29.8
	Other		0.2		0.6
	Total debt		307		352.7
	Less current portion of debt		81.2		115.2
	Total long-term debt	$	225.8	$	237.5
Schedule of Maturities of Long-Term Debt	'
	The following table summarizes the scheduled maturities of long-term debt for fiscal years 2014 through 2018:
		Term Loan
	2014	$	11.2
	2015	$	16.2
	2016	$	20
	2017	$	140
	2018	$	-

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Sep. 30, 2013
FAIR VALUE MEASUREMENTS [Abstract]	'
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	'
	The following table summarizes our financial assets and liabilities included in our Consolidated Balance Sheets, measured at fair value on a recurring basis:
						Quoted Prices in		Significant Other		Significant
						Active Markets for		Observable		Unobservable
			Balance at			Identical Assets		Inputs		Inputs
			30-Sep-13			(Level 1)		(Level 2)		(Level 3)
	Cash and cash equivalents		$	127.4		$	127.4	$	-	$	-
	Available-for-sale marketable securities			7.3			-		-		7.3
	Total assets at fair value		$	134.7		$	127.4	$	-	$	7.3
						Quoted Prices in		Significant Other		Significant
						Active Markets for		Observable		Unobservable
			Balance at			Identical Assets		Inputs		Inputs
			30-Sep-12			(Level 1)		(Level 2)		(Level 3)
	Cash and cash equivalents		$	84.3		$	84.3	$	-	$	-
	Available-for-sale marketable securities			7.3			-		-		7.3
	Total assets at fair value		$	91.6		$	84.3	$	-	$	7.3
Reconciliation of Level 3 Assets	'
	The following table presents the activity related to our ARS during the fiscal year.
			Available-For-Sale			AOCL		(Gain)/Loss
	Balance at October 1, 2012		$	7.3		$	0.5	$	-
	Change in fair value			-			-		-
	Sales or redemptions			-			-		-
	Balance at September 30, 2013		$	7.3		$	0.5	$	-
Schedule of Changes in Unrealized Gains (Losses)	'
	The components of the change in our unrealized gains (losses) were as follows:
				Years Ended September 30
				2013	2012		2011
	Unrealized gains (losses) on available-for sale securities:
		Unrealized holding gains (losses) arising during period, net-of-tax		$               -	$              0.7		$            (0.2)
		Less:  Reclassification adjustment for losses (gains) realized in net income, net-of-tax		-	0.1		-
	Net change in unrealized gains (losses), net-of-tax			$               -	$              0.8		$            (0.2)

RETIREMENT_AND_POSTRETIREMENT_1

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Tables)	12 Months Ended
	Sep. 30, 2013
Defined Benefit Retirement Plans [Member]	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Schedule of Components of Net Pension Expense	'
	The components of net periodic benefit cost for our defined benefit retirement plans were as follows:
		Years Ended September 30
		2013				2012			2011
	Service cost	$	6.1			$	5.5		$	5.2
	Interest cost		13.2				13.3			13.2
	Expected return on plan assets		(15.9	)			(16.7	)		(16.7	)
	Amortization of unrecognized prior service cost, net		0.6				0.6			0.6
	Amortization of net loss		7.8				6.1			4
	Net periodic benefit cost	$	11.8			$	8.8		$	6.3
Schedule of Changes in Obligations, Assets and Funded Status	'
	The change in benefit obligations, plan assets and funded status, along with amounts recognized in the Consolidated Balance Sheets for our defined benefit retirement plans were as follows:
		30-Sep
		2013				2012
	Change in benefit obligation:
	Benefit obligation at beginning of year	$	327.4			$	295.9
	Service cost		6.1				5.5
	Interest cost		13.2				13.3
	Actuarial (gain) loss		(41.1	)			21.7
	Benefits paid		(9.1	)			(8.5	)
	Acquisitions		-				0.1
	Amendments		0.6				-
	Exchange rate loss (gain)		0.8				(0.6	)
	Benefit obligation at end of year		297.9				327.4
	Change in plan assets:
	Fair value of plan assets at beginning of year		246.8				217.3
	Actual return on plan assets		15.7				37
	Employer contributions		1				1
	Benefits paid		(9.1	)			(8.5	)
	Fair value of plan assets at end of year		254.4				246.8
	Funded status and net amounts recognized	$	(43.5	)		$	(80.6	)
	Amounts recorded in the Consolidated Balance Sheets:
	Accrued pension benefits, current portion	$	(0.2	)		$	(0.1	)
	Accrued pension benefits, long-term		(43.3	)			(80.5	)
	Net amount recognized	$	(43.5	)		$	(80.6	)
Schedule of Accumulated Benefit Obligation	'
	The accumulated benefit obligation for all defined benefit pension plans was $278.8 million and $302.4 million at September 30, 2013 and 2012. Selected information for our plans, including plans with accumulated benefit obligations exceeding plan assets, was as follows:
		30-Sep
		2013										2012
		PBO				ABO			Plan Assets			PBO		ABO		Plan Assets
	Supplemental executive plan	$	3.9			$	3.7		$	-		$	4.4	$	4.2	$	-
	Master plan		279.2				261.7			254			309.5		285.7		246.4
	German plan		10.4				10.4			-			10.4		10.4		-
	French plan		4.4				3			0.4			3.1		2.1		0.4
		$	297.9			$	278.8		$	254.4		$	327.4	$	302.4	$	246.8
Schedule of Actuarial Assumptions	'
	The weighted average assumptions used in accounting for our domestic pension plans were as follows:
		2013			2012			2011
	Weighted average assumptions to determined benefit
	obligations at the measurement date:
	Discount rate for obligation	5.00%			4.10%			4.60%
	Rate of compensation increase	3.30%			3.30%			3.50%
	Weighted average assumptions to determined benefit
	cost for the year:
	Discount rate for expense	4.10%			4.60%			5.10%
	Expected rate of return on plan assets	7.00%			7.50%			7.50%
	Rate of compensation increase	3.30%			3.50%			3.50%
Schedule of Allocation of Plan Assets	'
	The weighted average asset allocations of our master defined benefit retirement plan at September 30, 2013 and 2012, by asset category, along with target allocations, are as follows:
		2013			2012			2013		2012
		Target			Target			Actual		Actual
		Allocation			Allocation			Allocation		Allocation
	Equity securities	40 - 60%			40 - 60%			57%		50%
	Fixed income securities	40 - 60%			40 - 60%			43%		50%
	Total							100%		100%
Schedule of Fair Value Measurements of Plan Assets	'
	The following table summarizes the valuation of our pension plan assets by pricing categories:
						Quoted Prices in			Significant
						Active Markets			Other			Significant
						for Identical			Observable			Unobservable
		Balance at				Assets			Inputs			Inputs
		30-Sep-13				(Level 1)			(Level 2)			(Level 3)
	Cash	$	3			$	3		$	-		$	-
	Equities
	US companies		101				101			-			-
	International companies		41.2				41.2			-			-
	Fixed income securities		108.8				59.1			49.7			-
	Other		0.4				0.4			-			-
	Total plan assets at fair value	$	254.4			$	204.7		$	49.7		$	-
						Quoted Prices in			Significant
						Active Markets			Other			Significant
						for Identical			Observable			Unobservable
		Balance at				Assets			Inputs			Inputs
		30-Sep-12				(Level 1)			(Level 2)			(Level 3)
	Cash	$	2.3			$	2.3		$	-		$	-
	Equities
	US companies		87.8				87.8			-			-
	International companies		34.9				34.9			-			-
	Fixed income securities		121.4				64.1			57.3			-
	Other		0.4				0.4			-			-
	Total plan assets at fair value	$	246.8			$	189.5		$	57.3		$	-
Schedule of Estimated Future Benefit Payments	'
	The benefit payments, which are expected to be funded through plan assets and company contributions and reflect expected future service, are expected to be paid as follows:
		Pension Benefits
	2014	$	10.8
	2015	$	11.6
	2016	$	12.5
	2017	$	13.4
	2018	$	14.2
	2019-2023	$	88.5
Postretirement Healthcare Plan [Member]	'
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]	'
Schedule of Changes in Obligations, Assets and Funded Status	'
	The postretirement health care plan reflected a credit during fiscal 2013, 2012 and 2011 of ($0.1) million, ($0.3) million and ($0.1) million.  The change in the accumulated postretirement benefit obligation was as follows:
		Years Ended September 30
		2013				2012
	Change in benefit obligation:
	Benefit obligation at beginning of year	$	9.6			$	9.5
	Service cost		0.4				0.4
	Interest cost		0.3				0.3
	Actuarial (gain) loss		(0.2	)			-
	Benefits paid		(0.5	)			(0.9	)
	Retiree contributions		0.2				0.3
	Benefit obligation at end of year	$	9.8			$	9.6
	Amounts recorded in the Consolidated Balance Sheets:
	Accrued benefits obligation, current portion	$	0.5			$	0.5
	Accrued benefits obligation, long-term		9.3				9.1
	Net amount recognized	$	9.8			$	9.6
Schedule of Health Care-Cost Trend Rates	'
	As of September 30, the health care-cost trend rates were assumed to decrease as follows:
		2013			2012			2011
	Year 1	6.25%			6.75%			7.25%
	Year 2	5.75%			6.25%			6.75%
	Year 3	5.25%			5.75%			6.25%
	Year 4	5.00%			5.25%			5.75%
	Year 5	5.00%			5.00%			5.25%
	Year 6	5.00%			5.00%			5.00%
	Year 7	5.00%			5.00%			5.00%
	Year 8 and beyond	5.00%			5.00%			5.00%

COMMON_STOCK_Tables

COMMON STOCK (Tables)	12 Months Ended
	Sep. 30, 2013
COMMON STOCK [Abstract]	'
Schedule of Stock-Based Compensation Cost	'
	The following table sets forth a summary of the annual stock-based compensation cost that was charged against income for all types of awards:
			Years Ended September 30
			2013			2012				2011
	Total stock-based compensation cost (pre-tax)		$	13.5		$	11.6			$	12.2
	Total income tax benefit			(4.9	)		(4.2	)			(4.5	)
	Total stock-based compensation cost, net of tax		$	8.6		$	7.4			$	7.7
Schedule of Weighted Average Fair Value per Share of Stock Options and Related Valuation Assumptions	'
	The following table sets forth the weighted average fair value per share of stock options and the related valuation assumptions used in the determination of those fair values:
			Years Ended September 30
			2013			2012				2011
	Weighted average fair value per share		$	7.91		$	9.79			$	12.31
	Valuation assumptions:
	Risk-free interest rate			0.60%			1.00%				1.20%
	Expected dividend yield			1.90%			1.40%				1.10%
	Expected volatility			40.20%			41.20%				37.30%
	Weighted average expected life			4.9 years			4.8 years				5.3 years
Schedule of Transactions under Stock Option Plans	'
	The following table summarizes transactions under our stock option plans for fiscal year 2013:
			Weighted						Weighted
			Average			Weighted			Average		Aggregate
			Number of			Average			Remaining		Intrinsic
			Shares			Exercise			Contractual		Value (1)
			(in thousands)			Price			Term		(in millions)
	Balance Outstanding at October 1, 2012			2,103		$	30.41
	Granted			501			26.94
	Exercised			(212	)		25.54
	Cancelled/Forfeited			(229	)		32.26
	Balance Outstanding at September 30, 2013			2,163		$	29.89		7.0 years		$	14.3
	Exercisable at September 30, 2013			969		$	29.63		5.5 years		$	6.8
	Options Expected to Vest			1,060		$	30.17		8.2 years		$	6.6
	-1	The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $35.83, as reported by the New York Stock Exchange on September 30, 2013. This amount, which changes continuously based on the fair value of our common stock, would have been received by the option holders had all option holders exercised their options as of the balance sheet date.
Schedule of Transactions for Nonvested RSUs	'
	The following table summarizes transactions for our nonvested RSUs for fiscal year 2013:
						Weighted
			Number of			Average
			Share Units			Grant Date
			(in thousands)			Fair Value
	Nonvested RSUs at October 1, 2012			307		$	30.38
	Granted			215			27.76
	Vested			(133	)		28.43
	Forfeited			(48	)		31.65
	Nonvested RSUs at September 30, 2013			341		$	29.34
Schedule of Weighted Average Fair Value per Share of PSUs and Related Valuation Assumptions	'
	The following table sets forth the weighted average fair value per share for total shareholder return PSUs and the related valuation assumptions used in the determination of those fair values:
			Years Ended September 30
			2013			2012
	Weighted average fair value per share		$	19.77		$	23.26
	Valuation assumptions:
	Risk-free interest rate			0.30%			0.40%
	Expected dividend yield			0.00%			0.00%
	Expected volatility			32.60%			35.60%
Schedule of Transactions for Nonvested PSUs	'
	The following table summarizes transactions for our nonvested PSUs for fiscal 2013:
						Weighted
			Number of			Average
			Share Units			Grant Date
			(in thousands)			Fair Value
	Nonvested PSUs as of October 1, 2012			392		$	25.4
	Granted			288			19.77
	Vested			-			-
	Forfeited			(106	)		24.69
	Nonvested PSUs at September 30, 2013			574		$	23.84

SPECIAL_CHARGES_Tables

SPECIAL CHARGES (Tables)	12 Months Ended
	Sep. 30, 2013
SPECIAL CHARGES [Abstract]	'
Restructuring Activity	'
	Severance activity related to these actions during fiscal 2013 was as follows:
		Beginning										Ending
		Balance										Balance
		September 30,										September 30,
		2012		Expenses		Cash Payments			Reversals			2013
	Fiscal 2013 Action	$	-	$	4.5	$	(1.9	)	$	-		$	2.6
	Prior Restructuring Actions		4.7		-		(3.8	)		(0.6	)		0.3
	Total	$	4.7	$	4.5	$	(5.7	)	$	(0.6	)	$	2.9

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Sep. 30, 2013
INCOME TAXES [Abstract]	'
Schedule of Components of Income before Income Taxes	'
	The significant components of income before income taxes and the consolidated income tax provision were as follows:
			Years Ended September 30
			2013			2012			2011
	Income before income taxes:
	Domestic		$	120		$	148.6		$	122.5
	Foreign			24			14.9			37.2
	Total		$	144		$	163.5		$	159.7
Schedule of Income Tax Expense	'
	Income tax expense:
	Current provision
	Federal		$	45		$	65.9		$	41.1
	State			1.8			4.3			2.3
	Foreign			7			4.8			4.3
	Total current provision			53.8			75			47.7
	Deferred provision:
	Federal			(9.9	)		(29.2	)		(0.8	)
	State			1.1			0.1			(0.2	)
	Foreign			(6.0	)		(3.2	)		(20.5	)
	Total deferred provision			(14.8	)		(32.3	)		(21.5	)
	Income tax expense		$	39		$	42.7		$	26.2
Reconciliation of Income Tax Expense to Income Taxes at Statutory Rate	'
	Differences between income tax expense reported for financial reporting purposes and that computed based upon the application of the statutory U.S. Federal tax rate to the reported income before income taxes were as follows:
			Years Ended September 30
			2013						2012						2011
						% of						% of						% of
						Pretax						Pretax						Pretax
			Amount			Income			Amount			Income			Amount			Income
	Federal income tax (a)		$	50.4			35		$	57.2			35		$	55.9			35
	State income tax (b)			2.5			1.7			3.5			2.2			2.4			1.5
	Foreign income tax (c)			(5.7	)		(4.0	)		(3.4	)		(2.1	)		(8.0	)		(5.0	)
	International tax restructuring			(0.8	)		(0.6	)		(11.0	)		(6.7	)		-			-
	Application of federal tax credits			(3.5	)		(2.4	)		(0.6	)		(0.4	)		(4.1	)		(2.5	)
	Adjustment of estimated income tax accruals			(1.5	)		(1.0	)		(2.1	)		(1.3	)		2.3			1.4
	Valuation of tax attributes			0.6			0.4			0.3			0.2			(19.5	)		(12.2	)
	Other, net			(3.0	)		(2.0	)		(1.2	)		(0.8	)		(2.8	)		(1.8	)
	Income tax expense		$	39			27.1		$	42.7			26.1		$	26.2			16.4
	(a)	At statutory rate.
	(b)	Net of Federal benefit.
	(c)	Federal tax rate differential.
Schedule of Deferred Taxes	'
	The tax effect of temporary differences that gave rise to the deferred tax balance sheet accounts were as follows:
			Years Ended September 30
			2013			2012
	Deferred tax assets:
	Employee benefit accruals		$	46.6		$	53.9
	Reserve for bad debts			10.1			12.4
	Accrued warranty			9.7			10.5
	Net operating loss carryforwards			38.3			39.4
	Tax credit carryforwards			2			1.8
	Other, net			23.7			26.7
				130.4			144.7
	Less:  Valuation allowance			(8.9	)		(8.6	)
	Total deferred tax assets			121.5			136.1
	Deferred tax liabilities:
	Depreciation			(32.1	)		(33.9	)
	Amortization			(67.5	)		(81.1	)
	Other, net			(3.2	)		(2.0	)
	Total deferred tax liabilities			(102.8	)		(117.0	)
	Deferred tax asset - net		$	18.7		$	19.1
Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits	'
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
			Years Ended September 30
			2013			2012			2011
	Balance at October 1		$	9.8		$	17.8		$	24
	Increases in tax position of prior years			-			0.5			0.4
	Decreases in tax position of prior years			(0.5	)		(2.7	)		(3.0	)
	Increases in tax positions related to the current year			0.1			-			5.1
	Settlements with taxing authorities			(3.2	)		(3.8	)		(5.2	)
	Lapse of applicable statute of limitations			(1.7	)		(1.9	)		(3.5	)
	Foreign currency adjustments			0.1			(0.1	)		-
	Total change			(5.2	)		(8.0	)		(6.2	)
	Balance at September 30		$	4.6		$	9.8		$	17.8

EARNINGS_PER_COMMON_SHARE_Tabl

EARNINGS PER COMMON SHARE (Tables)	12 Months Ended
	Sep. 30, 2013
EARNINGS PER COMMON SHARE [Abstract]	'
Calculated Earnings per Share	'
	Earnings per share is calculated as follows:
		Years Ended September 30
		2013		2012		2011
	Net income attributable to common shareholders	$	105	$	120.8	$	133.3
	Average shares outstanding - Basic (thousands)		59,910		62,120		63,164
	Add potential effect of exercise of stock options
	and other unvested equity awards (thousands)		340		241		735
	Average shares outstanding - Diluted (thousands)		60,250		62,361		63,899
	Net income attributable to common shareholders
	per common share - Basic	$	1.75	$	1.94	$	2.11
	Net income attributable to common shareholders
	per common share - Diluted	$	1.74	$	1.94	$	2.09

SEGMENT_REPORTING_Tables

SEGMENT REPORTING (Tables)	12 Months Ended
	Sep. 30, 2013
SEGMENT REPORTING [Abstract]	'
Reconciliation of Segment Information to Consolidated Financial Information	'
	We exclude such amounts from divisional income to allow management to evaluate and understand divisional operating trends without the effects of such items.
			Years Ended September 30
			2013			2012			2011
	Revenue:
	North America		$	958.3		$	998.2		$	1,057.20
	Surgical and Respiratory Care			245.8			153.2			132.9
	International			512.1			482.9			401.6
	Total revenue		$	1,716.20		$	1,634.30		$	1,591.70
	Divisional income:
	North America		$	194.6		$	208.4		$	228.3
	Surgical and Respiratory Care			46.1			41.7			40
	International			23.1			24.2			27.9
	Other operating costs:
	Corporate expenses and other non-allocated operating costs			103.2			82.9			80.7
	Impairment of goodwill and other intangibles			-			8			-
	Litigation (credit) charge			-			(3.6	)		47.3
	Special charges			5.7			18.2			1.4
	Operating profit			154.9			168.8			166.8
	Interest expense			(9.5	)		(6.5	)		(8.5	)
	Investment income and other, net			(1.4	)		1.2			1.4
	Income before income taxes		$	144		$	163.5		$	159.7
Schedule of Geographic Information	'
	Geographic data for net revenue and long-lived assets (which consist mainly of property and equipment leased to others) were as follows:
			Years Ended September 30
			2013			2012			2011
	Net revenue to unaffiliated customers: (a)
	United States		$	1,116.40		$	1,077.80		$	1,105.00
	Foreign			599.8			556.5			486.7
	Total revenue		$	1,716.20		$	1,634.30		$	1,591.70
	Long-lived assets: (b)
	United States		$	158		$	172.5		$	180.2
	Foreign			76.3			77.6			42.6
	Total long-lived assets		$	234.3		$	250.1		$	222.8
	(a)	Net revenue is attributed to geographic areas based on the location of the customer.
	(b)	Includes property and equipment leased to others.

QUARTERLY_FINANCIAL_INFORMATIO1

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Sep. 30, 2013
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) [Abstract]	'
Schedule of Selected Consolidated Financial Data	'
	The following table presents selected consolidated financial data by quarter for each of the last two fiscal years.
	2013 Quarter Ended	December 31,		March 31,		June 30,		September 30,
		2012		2013		2013		2013
	Net revenue	$	428.4	$	425.7	$	424.2	$	437.9
	Gross profit	$	191.4	$	196.1	$	190.1	$	202.7
	Net income attributable to common shareholders	$	24	$	22.3	$	23.4	$	35.3
	Basic net income attributable to common
	shareholders per common share	$	0.39	$	0.37	$	0.39	$	0.6
	Diluted net income attributable to common
	shareholders per common share	$	0.39	$	0.37	$	0.39	$	0.59
	2012 Quarter Ended	December 31,		March 31,		June 30,		September 30,
		2011		2012		2012		2012
	Net revenue	$	381.1	$	415.1	$	406.5	$	431.6
	Gross profit	$	185.1	$	195.8	$	172.7	$	201.1
	Net income attributable to common shareholders	$	32.9	$	25.3	$	23.4	$	39.2
	Basic net income attributable to common
	shareholders per common share	$	0.53	$	0.41	$	0.38	$	0.63
	Diluted net income attributable to common
	shareholders per common share	$	0.53	$	0.4	$	0.37	$	0.63

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Sep. 30, 2013
COMMITMENTS AND CONTINGENCIES [Abstract]	'
Schedule of Future Minimum Rental Payments	'
	Rental expense for fiscal years 2013, 2012 and 2011 was $21.5 million, $20.7 million and $20.0 million. The table below indicates the minimum annual rental commitments (excluding renewable periods) aggregating $61.6 million, for manufacturing facilities, warehouse distribution centers, service centers and sales offices, under non-cancelable operating leases.
		Amount
	2014	$	20.9
	2015	$	13.9
	2016	$	10.6
	2017	$	8.2
	2018	$	4.1
	2019 and beyond	$	3.9

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Principles of Consolidation and Investment Securities) (Details) (Encompass TSS, LLC [Member])	Nov. 30, 2010
Encompass TSS, LLC [Member]	'
Basis of Presentation and Principles of Consolidation	'
Noncontrolling ownership interest	40.00%

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Inventories) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012
In Millions, unless otherwise specified
Inventories	'	'
Percentage of LIFO inventory	47.00%	44.00%
Inventories consist of the following:	'	'
Finished products	$66.30	$71.80
Work in process	5.8	6.4
Raw materials	46.2	48.7
Total	118.3	126.9
Excess of current costs over reported LIFO value	$3.20	$3.10

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Property, Plant and Equipment) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Property, Plant and Equipment	'	'	'
Depreciation expense	$71.20	$73.90	$74.30
Major components of property and the related accumulated depreciation:	'	'	'
Cost	821.7	834.9	'
Accumulated Depreciation	587.4	584.8	'
Land Improvements [Member] | Minimum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'6 years	'	'
Land Improvements [Member] | Maximum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'15 years	'	'
Land and Land Improvements [Member]	'	'	'
Major components of property and the related accumulated depreciation:	'	'	'
Cost	14	16.1	'
Accumulated Depreciation	2.1	4.4	'
Buildings and Building Equipment [Member]	'	'	'
Major components of property and the related accumulated depreciation:	'	'	'
Cost	143.1	142.6	'
Accumulated Depreciation	84.6	85.8	'
Buildings and Building Equipment [Member] | Minimum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'10 years	'	'
Buildings and Building Equipment [Member] | Maximum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'40 years	'	'
Machinery and Equipment [Member]	'	'	'
Major components of property and the related accumulated depreciation:	'	'	'
Cost	288	276.3	'
Accumulated Depreciation	198.8	187.6	'
Machinery and Equipment [Member] | Minimum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'3 years	'	'
Machinery and Equipment [Member] | Maximum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'10 years	'	'
Equipment Leased to Others [Member]	'	'	'
Major components of property and the related accumulated depreciation:	'	'	'
Cost	376.6	399.9	'
Accumulated Depreciation	$301.90	$307	'
Equipment Leased to Others [Member] | Minimum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'2 years	'	'
Equipment Leased to Others [Member] | Maximum [Member]	'	'	'
Property, Plant and Equipment	'	'	'
Estimated useful life	'10 years	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Intangible Assets) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Goodwill:	'	'	'
Cost	$815.60	$808	$560
Amortization and Impairment	472.8	472.8	472.8
Other intangible assets:	'	'	'
Amortization expense	45.6	37.8	29.6
Total	'	'	'
Cost	1,316.60	1,305.60	'
Amortization and Impairment	721.1	679.6	'
Expected future amortization:	'	'	'
2014	39.8	'	'
2015	36.4	'	'
2016	29.2	'	'
2017	20.6	'	'
2018	17	'	'
2019 and beyond	76.8	'	'
Capitalized computer software:	'	'	'
Net book value of computer software costs	28.7	39.5	'
Amortization expense of capitalized software costs	17.8	20.7	19.1
Minimum [Member]	'	'	'
Other intangible assets:	'	'	'
Useful life	'3 years	'	'
Maximum [Member]	'	'	'
Other intangible assets:	'	'	'
Useful life	'20 years	'	'
Software [Member]	'	'	'
Other intangible assets:	'	'	'
Cost	164.6	163.2	'
Amortization and Impairment	135.9	123.7	'
Others [Member]	'	'	'
Other intangible assets:	'	'	'
Cost	336.4	334.4	'
Amortization and Impairment	$112.40	$83.10	'
Capitalized Software Costs [Member] | Minimum [Member]	'	'	'
Other intangible assets:	'	'	'
Useful life	'3 years	'	'
Capitalized Software Costs [Member] | Maximum [Member]	'	'	'
Other intangible assets:	'	'	'
Useful life	'10 years	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Guarantees) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Guarantees	'	'	'
Balance at October 1	$42.20	$17.80	$15.80
Provision for warranties during the period	29.2	31.8	17
Warranty reserves acquired	-2.6	9.7	'
Warranty claims incurred during the period	-30.7	-17.1	-15
Balance at September 30	38.1	42.2	17.8
Charge related to field corrective action	$12.20	$16	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Self Insurance) (Details) (Uninsured Risk [Member], USD $)	Sep. 30, 2013
Uninsured Risk [Member]	'
Loss Contingencies [Line Items]	'
Deductibles and self-insured retentions, minimum	$25,000
Deductibles and self-insured retentions, maximum	$1,000,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Research and Development and Advertising Costs) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Research and Development Costs	'	'	'
Research and development expenses	$70.20	$66.90	$63.80
Software development technology costs capitalized during the period	2.4	2.3	2.1
Advertising Costs	'	'	'
Advertising costs	$7.40	$4.40	$4

Recovered_Sheet1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
In Millions, unless otherwise specified
The composition of Accumulated Other Comprehensive Income (Loss) is as follows:	'	'	'
Available-for-sale securities and hedges	($0.30)	($0.40)	($0.90)
Foreign currency translation adjustment	-4.6	-17.2	-15.7
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs	-30.8	-60.4	-62.4
Total	($35.70)	($78)	($79)

ACQUISITIONS_Acquisition_of_As

ACQUISITIONS (Acquisition of Aspen) (Details) (USD $)	0 Months Ended	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jul. 23, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Business Acquisition [Line Items]	'	'	'	'
Purchase price of entity, net of cash acquired	'	($0.80)	$476.80	$15.50
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Goodwill	'	342.8	335.2	87.2
Aspen [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Purchase price of entity	402.2	'	'	'
Purchase price of entity, net of cash acquired	399.8	'	'	'
Purchase price adjustment	'	-1	'	'
Adjusted purchase price	401.2	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Inventory	25.6	'	'	'
Other current assets	19.7	'	'	'
Property, plant, and equipment	24.6	'	'	'
Goodwill	220.1	'	'	'
Trade name (Indefinite Lived)	29	'	'	'
Other noncurrent assets	1.6	'	'	'
Current liabilities	-14	'	'	'
Deferred tax liability	-41	'	'	'
Total purchase price	401.2	'	'	'
Pro Forma Information:	'	'	'	'
Total revenues	'	'	92.3	118.1
Impact to net income	'	'	5.7	11.1
Impact to earnings per diluted share	'	'	$0.09	$0.17
Aspen [Member] | Trade Name [Member]	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Intangible assets (Finite Lived)	4.6	'	'	'
Useful lives assigned to intangibles:	'	'	'	'
Weighted-average useful life	'15 years	'	'	'
Aspen [Member] | Customer Relationships [Member]	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Intangible assets (Finite Lived)	121.9	'	'	'
Useful lives assigned to intangibles:	'	'	'	'
Weighted-average useful life	'13 years	'	'	'
Aspen [Member] | Technology [Member]	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Intangible assets (Finite Lived)	$9.10	'	'	'
Useful lives assigned to intangibles:	'	'	'	'
Weighted-average useful life	'10 years	'	'	'

ACQUISITIONS_Acquisition_of_Vo

ACQUISITIONS (Acquisition of Volker) (Details) (USD $)	0 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Feb. 13, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Business Acquisition [Line Items]	'	'	'	'
Purchase price of entity, net of cash acquired	'	($0.80)	$476.80	$15.50
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Goodwill	'	342.8	335.2	87.2
Volker [Member]	'	'	'	'
Business Acquisition [Line Items]	'	'	'	'
Purchase price of entity	80.7	76.7	'	'
Purchase price of entity, net of cash acquired	77	'	'	'
Purchase price adjustment	'	4	'	'
Receivable from seller	'	1.2	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Goodwill	32.9	'	'	'
Net assets acquired	24.6	'	'	'
Deferred tax liability	-10.6	'	'	'
Total purchase price	76.7	'	'	'
Pro Forma Information:	'	'	'	'
Total revenues	'	'	49.9	117
Volker [Member] | Trade Name [Member]	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Intangible assets (Finite Lived)	12.3	'	'	'
Useful lives assigned to intangibles:	'	'	'	'
Weighted-average useful life	'7 years	'	'	'
Volker [Member] | Customer Relationships [Member]	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'
Intangible assets (Finite Lived)	$17.50	'	'	'
Useful lives assigned to intangibles:	'	'	'	'
Weighted-average useful life	'8 years	'	'	'

ACQUISITIONS_Encompass_Joint_V

ACQUISITIONS (Encompass Joint Venture) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011	Nov. 09, 2009	Nov. 30, 2010	Sep. 30, 2013	Nov. 09, 2009	Nov. 09, 2009	Nov. 09, 2009
In Millions, unless otherwise specified				Encompass TSS, LLC [Member]	Encompass TSS, LLC [Member]	Encompass TSS, LLC [Member]	Encompass TSS, LLC [Member]	Encompass TSS, LLC [Member]	Encompass TSS, LLC [Member]
							Trade Name [Member]	Customer Relationships [Member]	Technology [Member]
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'
Percent of entity owned	'	'	'	60.00%	'	'	'	'	'
Noncontrolling ownership interest	'	'	'	40.00%	'	'	'	'	'
Purchase price of entity	'	'	'	$7.50	'	'	'	'	'
Fair value of the assets acquired and liabilities assumed:	'	'	'	'	'	'	'	'	'
Goodwill	342.8	335.2	87.2	8	'	'	'	'	'
Intangible assets (Finite Lived)	'	'	'	'	'	'	1.5	7.7	2.4
Net liabilities assumed	'	'	'	-0.7	'	'	'	'	'
Noncontrolling interest	'	'	'	-7.5	'	'	'	'	'
Additional paid-in-capital	'	'	'	-3.9	'	'	'	'	'
Total purchase price	'	'	'	7.5	'	'	'	'	'
Useful lives assigned to intangibles:	'	'	'	'	'	'	'	'	'
Weighted-average useful life	'	'	'	'	'	'	'7 years	'7 years	'5 years
Payments to acquire additional interest in joint venture	'	'	'	'	10.6	'	'	'	'
Variable earn-out payment, minimum	'	'	'	'	1.2	'	'	'	'
Variable earn-out payment, maximum	'	'	'	'	1.6	'	'	'	'
Accrued other current liabilities and other long-term liabilities related to earn-out	'	'	'	'	'	$3	'	'	'

IMPAIRMENT_OF_GOODWILL_AND_OTH2

IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES (Schedule of Goodwill Activity) (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2012	Mar. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Goodwill [Line Items]	'	'	'	'	'
Goodwill	$808	'	$815.60	$808	$560
Accumulated impairment losses	-472.8	'	-472.8	-472.8	-472.8
Goodwill, net	335.2	'	342.8	335.2	87.2
Goodwill related to acquisitions	215.3	34.8	2.9	250.4	'
Currency translation effect	'	'	4.7	-2.4	'
North America Segment [Member]	'	'	'	'	'
Goodwill [Line Items]	'	'	'	'	'
Goodwill	383	'	383	383	383
Accumulated impairment losses	-358.1	'	-358.1	-358.1	-358.1
Goodwill, net	24.9	'	24.9	24.9	24.9
Goodwill related to acquisitions	'	'	'	'	'
Currency translation effect	'	'	'	'	'
Surgical and Respiratory Care Segment [Member]	'	'	'	'	'
Goodwill [Line Items]	'	'	'	'	'
Goodwill	271.5	'	279	271.5	56.2
Accumulated impairment losses	'	'	'	'	'
Goodwill, net	271.5	'	279	271.5	56.2
Goodwill related to acquisitions	'	'	4.8	215.3	'
Currency translation effect	'	'	2.7	'	'
International [Member]	'	'	'	'	'
Goodwill [Line Items]	'	'	'	'	'
Goodwill	153.5	'	153.6	153.5	120.8
Accumulated impairment losses	-114.7	'	-114.7	-114.7	-114.7
Goodwill, net	38.8	'	38.9	38.8	6.1
Goodwill related to acquisitions	'	'	-1.9	35.1	'
Currency translation effect	'	'	$2	($2.40)	'

IMPAIRMENT_OF_GOODWILL_AND_OTH3

IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES (Narrative) (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2012	Mar. 31, 2012	Sep. 30, 2013	Sep. 30, 2012
IMPAIRMENT OF GOODWILL AND OTHER INTANGIBLES [Abstract]	'	'	'	'
Loss on impairment of intangible assets	'	$8	'	'
Goodwill related to acquisitions	215.3	34.8	2.9	250.4
Indefinite-lived intangible assets	$32.90	'	$32.90	$32.90

FINANCING_AGREEMENTS_Schedule_

FINANCING AGREEMENTS (Schedule of Total Debt) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	$307	$352.70
Less current portion of debt	81.2	115.2
Total long-term debt	225.8	237.5
Outstanding Finance Credit Lines [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	'	0.2
Revolving Credit Facility [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	70	105
Term Loan [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	187.4	'
Less current portion of debt	11.2	10
Total long-term debt	176.2	187.5
Unsecured 7.00% Debentures due on February 15, 2024 [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	19.6	19.6
Unsecured debenture interest rate	7.00%	7.00%
Debt instrument, maturity date	15-Feb-24	'
Unsecured 6.75% Debentures due on December 15, 2027 [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	29.8	29.8
Unsecured debenture interest rate	6.75%	6.75%
Debt instrument, maturity date	15-Dec-27	'
Other [Member]	'	'
Long-term Debt, by Current and Noncurrent [Abstract]	'	'
Total debt	$0.20	$0.60

FINANCING_AGREEMENTS_Schedule_1

FINANCING AGREEMENTS (Schedule of Maturities of Long-Term Debt) (Details) (USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
FINANCING AGREEMENTS [Abstract]	'
2014	$11.20
2015	16.2
2016	20
2017	140
2018	'

FINANCING_AGREEMENTS_Narrative

FINANCING AGREEMENTS (Narrative) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013
In Millions, unless otherwise specified			Interest Rate Swap [Member]	New Credit Facility [Member]	Term Loan [Member]	Previous Credit Facility [Member]	Potential Increase to Revolving Credit Facility [Member]	Maximum [Member]	Minimum [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'
Deferred gains from the termination of previous interest rate swap agreements	$1	$1	'	'	'	'	'	'	'
Senior revolving credit facility, maximum borrowing amount	'	'	'	500	'	500	250	'	'
Aggregate value of debt	'	'	'	'	200	'	'	'	'
Credit facility expiration date	'	'	'	24-Aug-17	'	'	'	'	'
Percent of principal to be repaid over term	'	'	'	37.50%	'	'	'	'	'
Number of years under revolving credit facility	'	'	'	'5 years	'	'	'	'	'
Maximum interest rate during period	'	'	'	2.00%	'	'	'	'	'
Ratio of consolidated indebtedness to consolidated EBITDA	'	'	'	'	'	'	'	3.5	'
Interest coverage ratio	'	'	'	'	'	'	'	'	3.5
Outstanding borrowings	'	'	'	70	'	'	'	'	'
Undrawn letters of credit	'	'	'	5.3	'	'	'	'	'
Current borrowing capacity under the facility	'	'	'	424.7	'	'	'	'	'
Fair value of unsecured debentures	52.5	56.2	'	'	'	'	'	'	'
Fair value of term loan	185.5	197.5	'	'	'	'	'	'	'
Interest rate swap agreement, notional amount	'	'	135	'	'	'	'	'	'
Interest rate swap, fair value	$0.10	'	'	'	'	'	'	'	'

FAIR_VALUE_MEASUREMENTS_Schedu

FAIR VALUE MEASUREMENTS (Schedule of Fair Value of Assets Measured on a Recurring Basis) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012
In Millions, unless otherwise specified
AAA [Member] | Auction Rate Securities [Member]	'	'
Assets, Fair Value Disclosure [Abstract]	'	'
Available-for-sale marketable securities	$7.30	$7.30
Fair Value, Measurements, Recurring [Member]	'	'
Assets, Fair Value Disclosure [Abstract]	'	'
Cash and cash equivalents	127.4	84.3
Available-for-sale marketable securities	7.3	7.3
Total assets at fair value	134.7	91.6
Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'
Assets, Fair Value Disclosure [Abstract]	'	'
Cash and cash equivalents	127.4	84.3
Available-for-sale marketable securities	'	'
Total assets at fair value	127.4	84.3
Fair Value, Measurements, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'
Assets, Fair Value Disclosure [Abstract]	'	'
Cash and cash equivalents	'	'
Available-for-sale marketable securities	'	'
Total assets at fair value	'	'
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'
Assets, Fair Value Disclosure [Abstract]	'	'
Cash and cash equivalents	'	'
Available-for-sale marketable securities	7.3	7.3
Total assets at fair value	$7.30	$7.30

FAIR_VALUE_MEASUREMENTS_Reconc

FAIR VALUE MEASUREMENTS (Reconciliation of Level 3 Assets) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
AOCL	'	'	'
Balance at October 1, 2012	$0.40	$0.90	'
Balance at September 30, 2013	0.3	0.4	0.9
(Gain)/Loss	'	0.1	'
Auction Rate Securities [Member]	'	'	'
Available-For-Sale	'	'	'
Balance at October 1, 2012	7.3	'	'
Change in fair value	'	'	'
Sales or redemptions	'	'	'
Balance at September 30, 2013	7.3	'	'
AOCL	'	'	'
Balance at October 1, 2012	0.5	'	'
Change in fair value	'	'	'
Sales or redemptions	'	'	'
Balance at September 30, 2013	0.5	'	'
(Gain)/Loss	'	'	'

FAIR_VALUE_MEASUREMENTS_Inform

FAIR VALUE MEASUREMENTS (Information about Gains and Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Unrealized gains (losses) on available-for sale securities:	'	'	'
Unrealized holding gains (losses) arising during period, net-of-tax	'	$0.70	($0.20)
Less: Reclassification adjustment for losses (gains) realized in net income, net-of-tax	'	0.1	'
Net change in unrealized gains (losses), net-of-tax	'	0.8	-0.2
Recognized income:	'	'	'
Recognized income on investments excluding impairments	$0.60	$1.30	$2

RETIREMENT_AND_POSTRETIREMENT_2

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Net Periodic Benefit Cost) (Details) (Defined Benefit Retirement Plans [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Defined Benefit Retirement Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Service cost	$6.10	$5.50	$5.20
Interest cost	13.2	13.3	13.2
Expected return on plan assets	-15.9	-16.7	-16.7
Amortization of unrecognized prior service cost, net	0.6	0.6	0.6
Amortization of net loss	7.8	6.1	4
Net periodic benefit cost	$11.80	$8.80	$6.30

RETIREMENT_AND_POSTRETIREMENT_3

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Obligations and Funded Status) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Amounts recorded in the Consolidated Balance Sheets:	'	'	'
Accrued pension benefits, long-term	($52.60)	($89.60)	'
Defined Benefit Retirement Plans [Member]	'	'	'
Change in benefit obligation:	'	'	'
Benefit obligation at beginning of year	327.4	295.9	'
Service cost	6.1	5.5	5.2
Interest cost	13.2	13.3	13.2
Actuarial (gain) loss	-41.1	21.7	'
Benefits paid	-9.1	-8.5	'
Acquisitions	'	0.1	'
Amendments	0.6	'	'
Exchange rate loss (gain)	0.8	-0.6	'
Benefit obligation at end of year	297.9	327.4	295.9
Change in plan assets:	'	'	'
Fair value of plan assets at beginning of year	246.8	217.3	'
Actual return on plan assets	15.7	37	'
Employer contributions	1	1	'
Benefits paid	-9.1	-8.5	'
Fair value of plan assets at end of year	254.4	246.8	217.3
Funded status and net amounts recognized	-43.5	-80.6	'
Amounts recorded in the Consolidated Balance Sheets:	'	'	'
Accrued pension benefits, current portion	-0.2	-0.1	'
Accrued pension benefits, long-term	-43.3	-80.5	'
Net amount recognized	($43.50)	($80.60)	'

RETIREMENT_AND_POSTRETIREMENT_4

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Defined Contribution Savings Plans	'	'	'
Expense under plans	$15.80	$13.30	$13
Defined Benefit Retirement Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Net actuarial gains (losses) included in Accumulated Other Comprehensive Income (Loss)	51.3	100	'
Prior service credits (costs) included in Accumulated Other Comprehensive Income (Loss)	2.4	2.4	'
Pension items in AOCI, aggregate tax effect	20	38.7	'
Estimated net actuarial loss that will be amortized over the next fiscal year	3.2	'	'
Estimated prior service cost that will be amortized over the next fiscal year	0.6	'	'
Postretirement health care plan (benefit) cost	11.8	8.8	6.3
Accumulated Benefit Obligation	'	'	'
Accumulated benefit obligation	278.8	302.4	'
Plan Assets	'	'	'
Equity securities of one entity, maximum percentage of portfolio	10.00%	'	'
Cash Flows	'	'	'
Employer contributions	1	1	'
Postretirement Health Care Plan	'	'	'
Discount rate for expense	4.10%	4.60%	5.10%
Discount rate for obligation	5.00%	4.10%	4.60%
Postretirement Healthcare Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Net actuarial gains (losses) included in Accumulated Other Comprehensive Income (Loss)	1.8	1.6	'
Prior service credits (costs) included in Accumulated Other Comprehensive Income (Loss)	3	3.8	'
Pension items in AOCI, aggregate tax effect	-1.9	2.1	'
Estimated net actuarial loss that will be amortized over the next fiscal year	0	'	'
Estimated prior service cost that will be amortized over the next fiscal year	-0.9	'	'
Postretirement health care plan (benefit) cost	-0.1	-0.3	-0.1
Cash Flows	'	'	'
Employer contributions	0.3	0.6	'
Postretirement Health Care Plan	'	'	'
Discount rate for expense	3.30%	4.00%	4.40%
Discount rate for obligation	4.10%	3.30%	4.00%
Effect of one-percentage-point increase/decrease on service and interest costs	0.1	'	'
Effect of one-percentage-point increase on service and benefit obligation	0.9	'	'
Effect of one-percentage-point decrease on service and benefit obligation	0.8	'	'
Expected employer contributions required in 2014	0.5	'	'
Defined benefit plan estimated future employer contributions in next fiscal, per year, thereafter	$1	'	'

RETIREMENT_AND_POSTRETIREMENT_5

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Accumulated Benefit Obligation) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
In Millions, unless otherwise specified
Supplemental Executive Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
PBO	$3.90	$4.40	'
ABO	3.7	4.2	'
Plan Assets	'	'	'
Master Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
PBO	279.2	309.5	'
ABO	261.7	285.7	'
Plan Assets	254	246.4	'
German Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
PBO	10.4	10.4	'
ABO	10.4	10.4	'
Plan Assets	'	'	'
French Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
PBO	4.4	3.1	'
ABO	3	2.1	'
Plan Assets	0.4	0.4	'
Defined Benefit Retirement Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
PBO	297.9	327.4	295.9
ABO	278.8	302.4	'
Plan Assets	$254.40	$246.80	$217.30

RETIREMENT_AND_POSTRETIREMENT_6

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Actuarial Assumptions) (Details) (Defined Benefit Retirement Plans [Member])	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Defined Benefit Retirement Plans [Member]	'	'	'
Weighted average assumptions to determined benefit obligations at the measurement date:	'	'	'
Discount rate for obligation	5.00%	4.10%	4.60%
Rate of compensation increase	3.30%	3.30%	3.50%
Weighted average assumptions to determined benefit cost for the year:	'	'	'
Discount rate for expense	4.10%	4.60%	5.10%
Expected rate of return on plan assets	7.00%	7.50%	7.50%
Rate of compensation increase	3.30%	3.50%	3.50%

RETIREMENT_AND_POSTRETIREMENT_7

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Allocation of Plan Assets) (Details) (Defined Benefit Retirement Plans [Member])	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Defined Benefit Plan Disclosure [Line Items]	'	'
Actual allocation	100.00%	100.00%
Equity Securities [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Target allocation, minimum	40.00%	40.00%
Target allocation, maximum	60.00%	60.00%
Actual allocation	57.00%	50.00%
Fixed Income Securities [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Target allocation, minimum	40.00%	40.00%
Target allocation, maximum	60.00%	60.00%
Actual allocation	43.00%	50.00%

RETIREMENT_AND_POSTRETIREMENT_8

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Fair Value Measurements of Plan Assets) (Details) (Defined Benefit Retirement Plans [Member], USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
In Millions, unless otherwise specified
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	$254.40	$246.80	$217.30
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	204.7	189.5	'
Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	49.7	57.3	'
Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
Cash [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	3	2.3	'
Cash [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	3	2.3	'
Cash [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
Cash [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
US Companies [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	101	87.8	'
US Companies [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	101	87.8	'
US Companies [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
US Companies [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
International Companies [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	41.2	34.9	'
International Companies [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	41.2	34.9	'
International Companies [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
International Companies [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
Fixed Income Securities [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	108.8	121.4	'
Fixed Income Securities [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	59.1	64.1	'
Fixed Income Securities [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	49.7	57.3	'
Fixed Income Securities [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
Other [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	0.4	0.4	'
Other [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	0.4	0.4	'
Other [Member] | Significant Other Observable Inputs (Level 2) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'
Other [Member] | Significant Unobservable Inputs (Level 3) [Member]	'	'	'
Fair Value Measurements of Plan Assets	'	'	'
Plan assets at fair value	'	'	'

RETIREMENT_AND_POSTRETIREMENT_9

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Estimated Future Benefit Payments) (Details) (Defined Benefit Retirement Plans [Member], USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
Defined Benefit Retirement Plans [Member]	'
Estimated Future Benefit Payments	'
2014	$10.80
2015	11.6
2016	12.5
2017	13.4
2018	14.2
2019 - 2023	$88.50

Recovered_Sheet2

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Postretirement Health Care Plan) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Amounts recorded in the Consolidated Balance Sheets:	'	'
Accrued benefits obligation, long-term	$52.60	$89.60
Postretirement Healthcare Plan [Member]	'	'
Change in benefit obligation:	'	'
Benefit obligation at beginning of year	9.6	9.5
Service cost	0.4	0.4
Interest cost	0.3	0.3
Actuarial gain	-0.2	'
Benefits paid	-0.5	-0.9
Retiree contributions	0.2	0.3
Benefit obligation at end of year	9.8	9.6
Amounts recorded in the Consolidated Balance Sheets:	'	'
Accrued benefits obligation, current portion	0.5	0.5
Accrued benefits obligation, long-term	9.3	9.1
Net amount recognized	$9.80	$9.60

Recovered_Sheet3

RETIREMENT AND POSTRETIREMENT BENEFIT PLANS (Schedule of Health Care-Cost Trend Rates) (Details) (Postretirement Healthcare Plan [Member])	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Postretirement Healthcare Plan [Member]	'	'	'
Assumed health care cost trend rates:	'	'	'
Year 1	6.25%	6.75%	7.25%
Year 2	5.75%	6.25%	6.75%
Year 3	5.25%	5.75%	6.25%
Year 4	5.00%	5.25%	5.75%
Year 5	5.00%	5.00%	5.25%
Year 6	5.00%	5.00%	5.00%
Year 7	5.00%	5.00%	5.00%
Year 8 and beyond	5.00%	5.00%	5.00%

COMMON_STOCK_Narrative_Details

COMMON STOCK (Narrative) (Details) (USD $)

1 Months Ended

12 Months Ended

12 Months Ended

In Millions, except Share data, unless otherwise specified

Sep. 30, 2013

Aug. 31, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2011

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Performance Shares [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Share Repurchases

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares repurchased

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,800,000

1,500,000

3,000,000

Value of shares repurchased

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$92.70

$42.40

$110

Value of share repurchase authorization

190

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares remaining for purchase under the Board's authorization

'

1,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock-Based Compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares authorized

15,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares available for future grants

4,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury stock, shares

21,800,520

'

19,526,989

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vesting period

'

'

'

'

'

'

'3 years

'4 years

'

'

'

'1 year

'5 years

'

'

'

'

Maximum contractual term

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Total intrinsic value of options exercised

'

'

'

1.6

1.3

23.3

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation expense

'

'

'

6.7

'

'

'

'

5.9

'

'

'

'

6.2

'

'

'

Unrecognized compensation expense, weighted-average recognition period

'

'

'

'1 year 10 months 24 days

'

'

'

'

'2 years

'

'

'

'

'

'

'

'

Total vest date fair value of shares that vested

'

'

'

'

'

'

'

'

$5.80

$6.80

$15.90

'

'

'

'

'

'

COMMON_STOCK_Schedule_of_Stock

COMMON STOCK (Schedule of Stock-Based Compensation Cost) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
COMMON STOCK [Abstract]	'	'	'
Total stock-based compensation cost (pre-tax)	$13.50	$11.60	$12.20
Total income tax benefit	-4.9	-4.2	-4.5
Total stock-based compensation cost, net of tax	$8.60	$7.40	$7.70

COMMON_STOCK_Schedule_of_Weigh

COMMON STOCK (Schedule of Weighted Average Fair Value per Share of Stock Options and Related Valuation Assumptions) (Details) (Stock Options [Member], USD $)	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Stock Options [Member]	'	'	'
Stock Options	'	'	'
Weighted average fair value per share	$7.91	$9.79	$12.31
Valuation assumptions:	'	'	'
Risk-free interest rate	0.60%	1.00%	1.20%
Expected dividend yield	1.90%	1.40%	1.10%
Expected volatility	40.20%	41.20%	37.30%
Weighted average expected life	'4 years 10 months 24 days	'4 years 9 months 18 days	'5 years 3 months 18 days

COMMON_STOCK_Schedule_of_Trans

COMMON STOCK (Schedule of Transactions under Stock Option Plans) (Details) (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Sep. 30, 2013
Stock-Based Compensation	'
Closing stock price	$35.83
Stock Options [Member]	'
Weighted Average Number of Shares	'
Balance Outstanding at October 1, 2012	2,103
Granted	501
Exercised	-212
Cancelled/Forfeited	-229
Balance Outstanding at September 30, 2013	2,163
Exercisable at September 30, 2013	969
Options Expected to Vest	1,060
Weighted Average Exercise Price	'
Balance Outstanding at October 1, 2012	$30.41
Granted	$26.94
Exercised	$25.54
Cancelled/Forfeited	$32.26
Balance Outstanding at September 30, 2013	$29.89
Exercisable at September 30, 2013	$29.63
Options Expected to Vest	$30.17
Weighted Average Remaining Contractual Term	'
Balance Outstanding at September 30, 2013	'7 years 0 months
Exercisable at September 30, 2013	'5 years 6 months
Options Expected to Vest	'8 years 2 months 12 days
Aggregate Intrinsic Value	'
Balance Outstanding at September 30, 2013	$14.30	[1]
Exercisable at September 30, 2013	6.8	[1]
Options Expected to Vest	$6.60	[1]
[1]	The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $35.83, as reported by the New York Stock Exchange on September 30, 2013. This amount, which changes continuously based on the fair value of our common stock, would have been received by the option holders had all option holders exercised their options as of the balance sheet date.

COMMON_STOCK_Schedule_of_Trans1

COMMON STOCK (Schedule of Transactions for Nonvested RSUs) (Details) (Restricted Stock Units (RSUs) [Member], USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013
Restricted Stock Units (RSUs) [Member]	'
Number of Share Units	'
Nonvested at October 1, 2012	307
Granted	215
Vested	-133
Forfeited	-48
Nonvested at September 30, 2013	341
Weighted Average Grant Date Fair Value	'
Nonvested at October 1, 2012	$30.38
Granted	$27.76
Vested	$28.43
Forfeited	$31.65
Nonvested at September 30, 2013	$29.34

COMMON_STOCK_Schedule_of_Weigh1

COMMON STOCK (Schedule of Weighted Average Fair Value per Share PSUs and Related Valuation Assumptions) (Details) (Performance Shares [Member], USD $)	12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Performance Shares [Member]	'	'
Performance Share Units	'	'
Weighted average fair value per share	$19.77	$23.26
Valuation assumptions:	'	'
Risk-free interest rate	0.30%	0.40%
Expected dividend yield	0.00%	0.00%
Expected volatility	32.60%	35.60%

COMMON_STOCK_Schedule_of_Trans2

COMMON STOCK (Schedule of Transactions for Nonvested PSUs) (Details) (Performance Shares [Member], USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013
Performance Shares [Member]	'
Number of Share Units	'
Nonvested at October 1, 2012	392
Granted	288
Vested	'
Forfeited	-106
Nonvested at September 30, 2013	574
Weighted Average Grant Date Fair Value	'
Nonvested at October 1, 2012	$25.40
Granted	$19.77
Vested	'
Forfeited	$24.69
Nonvested at September 30, 2013	$23.84

SPECIAL_CHARGES_Narrative_Deta

SPECIAL CHARGES (Narrative) (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

In Millions, unless otherwise specified

Mar. 31, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2011

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Sep. 30, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Mar. 31, 2012

Sep. 30, 2012

Sep. 30, 2012

Mar. 31, 2011

Jun. 30, 2011

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2013 Action [Member]

Fiscal Year 2012 Action [Member]

Fiscal Year 2012 Action [Member]

Fiscal Year 2012 Action [Member]

Fiscal Year 2012 Action [Member]

Fiscal Year 2012 Action [Member]

Fiscal Year 2010 Action [Member]

Fiscal Year 2010 Action [Member]

employees

Employee Severance [Member]

Impairment of Certain Tangible Assets [Member]

Contract Termination [Member]

Other Restructuring [Member]

employees

employees

Employee Severance [Member]

Employee Severance [Member]

Restructuring Cost and Reserve [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of positions planned to be eliminated

'

'

'

'

'

'

100

'

'

'

'

'

'

100

200

'

'

'

'

Special charges

'

$5.70

$18.20

$1.40

$2

$0.80

'

'

$1.70

$0.60

$0.20

$1

'

'

'

$9.30

$1

$2.60

'

Restructuring reserve reversal

'

0.6

'

'

'

'

'

'

'

'

'

'

0.6

'

'

'

'

'

1.2

Loss on impairment of intangible assets

8

'

'

'

'

'

'

'

'

'

'

'

'

'

8

'

'

'

'

Impairment of certain tangible assets

'

'

'

'

'

'

'

'

'

'

'

'

'

$4.70

$3.20

'

'

'

'

SPECIAL_CHARGES_Schedule_of_Ac

SPECIAL CHARGES (Schedule of Activity) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013
Restructuring Reserve [Roll Forward]	'
Beginning Balance	$4.70
Expenses	4.5
Cash Payments	-5.7
Reversals	-0.6
Ending Balance	2.9
Fiscal Year 2013 Action [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning Balance	'
Expenses	4.5
Cash Payments	-1.9
Reversals	'
Ending Balance	2.6
Prior Restructuring Actions [Member]	'
Restructuring Reserve [Roll Forward]	'
Beginning Balance	4.7
Expenses	'
Cash Payments	-3.8
Reversals	-0.6
Ending Balance	$0.30

INCOME_TAXES_Schedule_of_Compo

INCOME TAXES (Schedule of Components of Income before Income Taxes and the Consolidated Income Tax Provision) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Income before income taxes:	'	'	'
Domestic	$120	$148.60	$122.50
Foreign	24	14.9	37.2
Total	144	163.5	159.7
Current provision	'	'	'
Federal	45	65.9	41.1
State	1.8	4.3	2.3
Foreign	7	4.8	4.3
Total current provision	53.8	75	47.7
Deferred provision:	'	'	'
Federal	-9.9	-29.2	-0.8
State	1.1	0.1	-0.2
Foreign	-6	-3.2	-20.5
Total deferred provision	-14.8	-32.3	-21.5
Income tax expense	$39	$42.70	$26.20

INCOME_TAXES_Schedule_of_Diffe

INCOME TAXES (Schedule of Differences between Income Tax Expense) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2011
Amount	'		'		'
Federal income tax	$50.40	[1]	$57.20	[1]	$55.90	[1]
State income tax	2.5	[2]	3.5	[2]	2.4	[2]
Foreign income tax	-5.7	[3]	-3.4	[3]	-8	[3]
International tax restructuring	-0.8		-11		'
Application of federal tax credits	-3.5		-0.6		-4.1
Adjustment of estimated income tax accruals	-1.5		-2.1		2.3
Valuation of tax attributes	0.6		0.3		-19.5
Other, net	-3		-1.2		-2.8
Income tax expense	$39		$42.70		$26.20
% of Pretax Income	'		'		'
Federal income tax	35.00%	[1]	35.00%	[1]	35.00%	[1]
State income tax	1.70%	[2]	2.20%	[2]	1.50%	[2]
Foreign income tax	-4.00%	[3]	-2.10%	[3]	-5.00%	[3]
International tax restructuring	-0.60%		-6.70%		'
Application of federal tax credits	-2.40%		-0.40%		-2.50%
Adjustment of estimated income tax accruals	-1.00%		-1.30%		1.40%
Valuation of tax attributes	0.40%		0.20%		-12.20%
Other, net	-2.00%		-0.80%		-1.80%
Income tax expense	27.10%		26.10%		16.40%
[1]	At statutory rate.
[2]	Net of Federal benefit.
[3]	Federal tax rate differential.

INCOME_TAXES_Schedule_of_Defer

INCOME TAXES (Schedule of Deferred Taxes) (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012
In Millions, unless otherwise specified
Deferred tax assets:	'	'
Employee benefit accruals	$46.60	$53.90
Reserve for bad debts	10.1	12.4
Accrued warranty	9.7	10.5
Net operating loss carryforwards	38.3	39.4
Tax credit carryforwards	2	1.8
Other, net	23.7	26.7
Deferred Tax Assets, Gross, Total	130.4	144.7
Less: Valuation allowance	-8.9	-8.6
Total deferred tax assets	121.5	136.1
Deferred tax liabilities:	'	'
Depreciation	-32.1	-33.9
Amortization	-67.5	-81.1
Other, net	-3.2	-2
Total deferred tax liabilities	-102.8	-117
Deferred tax asset - net	$18.70	$19.10

INCOME_TAXES_Narrative_Details

INCOME TAXES (Narrative) (Details) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2010
Income taxes:	'	'	'	'
Deferred tax assets related to operating loss carryforwards in foreign jurisdictions	$37.70	'	'	'
Deferred tax assets related to state net operating loss carryforwards	0.6	'	'	'
Deferred tax assets related to state credits	2	'	'	'
One-time tax benefit related to restructuring of a portion of international operations	-0.8	-11	'	'
Valuation allowance on deferred tax assets	8.9	8.6	'	'
Estimated decrease in unrecognized tax benefits, lower bound	2	'	'	'
Estimated decrease in unrecognized tax benefits, upper bound	3	'	'	'
Total gross unrecognized tax benefits	4.6	9.8	17.8	24
Unrecognized tax benefits that would impact effective tax rate, if recognized	3.9	8.4	11.5	'
Accrued interest and penalties related to unrecognized tax benefits	0.6	0.8	1.9	'
Income tax expense for interest and penalties	0.1	0.1	-0.1	'
Income Tax Holiday [Line Items]	'	'	'	'
Impact of tax holidays	$2.90	$1.70	$0.70	'
Benefit of tax holidays on net income per share (diluted)	$0.05	$0.03	$0.01	'
Singapore Tax Authority [Member]	'	'	'	'
Income Tax Holiday [Line Items]	'	'	'	'
Income tax holiday, year of expiration	'2016	'	'	'
Puerto Rico Tax Authority [Member]	'	'	'	'
Income Tax Holiday [Line Items]	'	'	'	'
Income tax holiday, year of expiration	'2025	'	'	'
Minimum [Member]	'	'	'	'
Income taxes:	'	'	'	'
Operating loss carryforwards, year of expiration	1-Jan-18	'	'	'
Tax credit carryforwards, year of expiration	1-Jan-14	'	'	'
Maximum [Member]	'	'	'	'
Income taxes:	'	'	'	'
Operating loss carryforwards, year of expiration	31-Dec-26	'	'	'
Tax credit carryforwards, year of expiration	31-Dec-26	'	'	'

INCOME_TAXES_Reconciliation_of

INCOME TAXES (Reconciliation of Unrecognized Tax Benefits) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:	'	'	'
Balance at October 1	$9.80	$17.80	$24
Increases in tax position of prior years	'	0.5	0.4
Decreases in tax position of prior years	-0.5	-2.7	-3
Increases in tax positions related to the current year	0.1	'	5.1
Settlements with taxing authorities	-3.2	-3.8	-5.2
Lapse of applicable statute of limitations	-1.7	-1.9	-3.5
Foreign currency adjustments	0.1	-0.1	'
Total change	-5.2	-8	-6.2
Balance at September 30	$4.60	$9.80	$17.80

EARNINGS_PER_COMMON_SHARE_Deta

EARNINGS PER COMMON SHARE (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
EARNINGS PER COMMON SHARE [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Anti-dilutive stock options excluded from calculation of dilutive earnings per share	'	'	'	'	'	'	'	'	1,400,000	1,400,000	600,000
Earnings per share is calculated as follows:	'	'	'	'	'	'	'	'	'	'	'
Net income attributable to common shareholders	'	'	'	'	'	'	'	'	$105	$120.80	$133.30
Average shares outstanding - Basic (thousands)	'	'	'	'	'	'	'	'	59,910,000	62,120,000	63,164,000
Add potential effect of exercise of stock options and other unvested equity awards (thousands)	'	'	'	'	'	'	'	'	340,000	241,000	735,000
Average shares outstanding - Diluted (thousands)	'	'	'	'	'	'	'	'	60,250,000	62,361,000	63,899,000
Net income attributable to common shareholders per common share - Basic	$0.60	$0.39	$0.37	$0.39	$0.63	$0.38	$0.41	$0.53	$1.75	$1.94	$2.11
Net income attributable to common shareholders per common share - Diluted	$0.59	$0.39	$0.37	$0.39	$0.63	$0.37	$0.40	$0.53	$1.74	$1.94	$2.09

SEGMENT_REPORTING_Schedule_of_

SEGMENT REPORTING (Schedule of Segment Information) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenue	$437.90	$424.20	$425.70	$428.40	$431.60	$406.50	$415.10	$381.10	$1,716.20	$1,634.30	$1,591.70
Impairment of goodwill and other intangibles	'	'	'	'	'	'	'	'	'	8	'
Litigation (credit) charge	'	'	'	'	'	'	'	'	'	-3.6	47.3
Special charges	'	'	'	'	'	'	'	'	5.7	18.2	1.4
Operating profit	'	'	'	'	'	'	'	'	154.9	168.8	166.8
Interest expense	'	'	'	'	'	'	'	'	-9.5	-6.5	-8.5
Investment income and other, net	'	'	'	'	'	'	'	'	-1.4	1.2	1.4
Income Before Income Taxes	'	'	'	'	'	'	'	'	144	163.5	159.7
Corporate and Other [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Operating profit	'	'	'	'	'	'	'	'	-103.2	-82.9	-80.7
Segment Reconciling Items [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Impairment of goodwill and other intangibles	'	'	'	'	'	'	'	'	'	8	'
Litigation (credit) charge	'	'	'	'	'	'	'	'	'	-3.6	47.3
Special charges	'	'	'	'	'	'	'	'	5.7	18.2	1.4
North America Segment [Member] | Operating Segments [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	958.3	998.2	1,057.20
Operating profit	'	'	'	'	'	'	'	'	194.6	208.4	228.3
Surgical and Respiratory Care Segment [Member] | Operating Segments [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	245.8	153.2	132.9
Operating profit	'	'	'	'	'	'	'	'	46.1	41.7	40
International [Member] | Operating Segments [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	512.1	482.9	401.6
Operating profit	'	'	'	'	'	'	'	'	$23.10	$24.20	$27.90

SEGMENT_REPORTING_Schedule_of_1

SEGMENT REPORTING (Schedule of Geographic Information) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2011
Geographic Information	'		'		'
Revenue	$1,716.20	[1]	$1,634.30	[1]	$1,591.70	[1]
Long-lived assets	234.3	[2]	250.1	[2]	222.8	[2]
United States [Member]	'		'		'
Geographic Information	'		'		'
Revenue	1,116.40	[1]	1,077.80	[1]	1,105	[1]
Long-lived assets	158	[2]	172.5	[2]	180.2	[2]
Foreign [Member]	'		'		'
Geographic Information	'		'		'
Revenue	599.8	[1]	556.5	[1]	486.7	[1]
Long-lived assets	$76.30	[2]	$77.60	[2]	$42.60	[2]
[1]	Net revenue is attributed to geographic areas based on the location of the customer.
[2]	Includes property and equipment leased to others.

QUARTERLY_FINANCIAL_INFORMATIO2

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net revenue	$437.90	$424.20	$425.70	$428.40	$431.60	$406.50	$415.10	$381.10	$1,716.20	$1,634.30	$1,591.70
Gross profit	202.7	190.1	196.1	191.4	201.1	172.7	195.8	185.1	780.3	754.7	781.3
Net income attributable to common shareholders	$35.30	$23.40	$22.30	$24	$39.20	$23.40	$25.30	$32.90	$105	$120.80	$133.30
Basic net income attributable to common shareholders per common share	$0.60	$0.39	$0.37	$0.39	$0.63	$0.38	$0.41	$0.53	$1.75	$1.94	$2.11
Diluted net income attributable to common shareholders per common share	$0.59	$0.39	$0.37	$0.39	$0.63	$0.37	$0.40	$0.53	$1.74	$1.94	$2.09

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Lease Commitments and Long-Term Agreement) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Lease Commitments	'	'	'
Rental expense	$21.50	$20.70	$20
Minimum annual rental commitments	61.6	'	'
2014	20.9	'	'
2015	13.9	'	'
2016	10.6	'	'
2017	8.2	'	'
2018	4.1	'	'
2019 and beyond	3.9	'	'
Payment of contract termination fee	$0.60	'	'

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Self Insurance and Legal Proceedings) (Details) (USD $)	12 Months Ended				3 Months Ended	1 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2013	Jun. 30, 2011	Sep. 30, 2011
				Uninsured Risk [Member]	Office of Inspector General Investigation [Member]	Freedom Medical Antitrust Litigation [Member]
Loss Contingencies [Line Items]	'	'	'	'	'	'
Litigation charge	'	$3,600,000	($47,300,000)	'	($42,300,000)	'
Cash payment for settlement	'	'	'	'	'	5,000,000
Deductibles and self-insured retentions, minimum	'	'	'	25,000	'	'
Deductibles and self-insured retentions, maximum	'	'	'	$1,000,000	'	'

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2011
Allowance for Possible Losses and Sales Returns - Accounts Receivable [Member]	'		'		'
Reserves deducted from assets to which they apply:	'		'		'
BALANCE AT BEGINNING OF PERIOD	$38.50		$26.70		$29
CHARGED TO COSTS AND EXPENSES	2.7		1.6		1.5
CHARGED TO OTHER ACCOUNTS	-0.1	[1]	18.5	[1]	3.1	[1]
DEDUCTIONS NET OF RECOVERIES	-11	[2]	-8.3	[2]	-6.9	[2]
BALANCE AT END OF PERIOD	30.1		38.5		26.7
Allowance for Inventory Valuation [Member]	'		'		'
Reserves deducted from assets to which they apply:	'		'		'
BALANCE AT BEGINNING OF PERIOD	22		22.9		24.7
CHARGED TO COSTS AND EXPENSES	1.8		2.2		3.7
CHARGED TO OTHER ACCOUNTS	'	[3]	1.6	[3]	'	[3]
DEDUCTIONS NET OF RECOVERIES	-1.8	[4]	-4.7	[4]	-5.5	[4]
BALANCE AT END OF PERIOD	22		22		22.9
Valuation Allowance Against Deferred Tax Assets [Member]	'		'		'
Reserves deducted from assets to which they apply:	'		'		'
BALANCE AT BEGINNING OF PERIOD	8.6		8.1		28.5
CHARGED TO COSTS AND EXPENSES	0.6		0.4		-19.5
CHARGED TO OTHER ACCOUNTS	'		'		'
DEDUCTIONS NET OF RECOVERIES	-0.3	[5]	0.1	[5]	-0.9	[5]
BALANCE AT END OF PERIOD	$8.90		$8.60		$8.10
[1]	Reduction of gross revenue for uncollectible health care rental reimbursements, cash discounts and other adjustments in determining net revenue. Also includes the effect of acquired businesses, if any.
[2]	Generally reflects the write-off of specific receivables against recorded reserves.
[3]	Generally reflects the effect of acquired businesses, if any.
[4]	Generally reflects the write-off of specific inventory against recorded reserves.
[5]	Primarily reflects write-offs of deferred tax assets against the valuation allowance and other movement of the valuation allowance offset by an opposing change in deferred tax assets.